Reports

In Q1 2025, Shopify delivered $2.36B in revenue, driven by growth in both subscription and merchant solutions. However, the company posted a $682M net loss primarily due to a $1B unrealized loss on equity investments.

• Revenue reached $2.36 billion, continuing strong top-line momentum.
• GAAP net loss was $682 million, heavily impacted by a $1 billion unrealized investment loss.

Brookfield Corporation delivered a robust quarter in Q1 2025, supported by strong performance in asset management and wealth solutions, growing its distributable earnings to $1.5 billion and deploying significant capital while continuing aggressive share repurchases.

• Total distributable earnings rose to $1.5 billion in Q1 2025.
• Fee-related earnings in asset management hit a record $698 million, supported by $25 billion in inflows.

AB InBev delivered strong financial performance in Q1 2025, with EBITDA growing 7.9%, EPS up 7.1%, and net income nearly doubling due to non-underlying items. Despite volume declines, strategic execution and digital expansion supported profitability.

• Normalized EBITDA rose 7.9% to $4.855 billion, with margin expansion of 218bps.
• Net income increased to $2.148 billion from $1.091 billion a year earlier.

McKesson delivered a robust Q4 FY25 performance, driven by growth in U.S. pharmaceutical and specialty product volumes, particularly in oncology. The company posted a solid rise in EPS and operating income, and announced plans to separate its Medical-Surgical Solutions segment.

• Q4 revenue increased 19% year-over-year, driven by strength in U.S. Pharmaceutical.
• Adjusted EPS rose to $10.12, reflecting strong operational performance and a favorable tax rate.

Coinbase posted $2.03 billion in revenue and $66 million in net income for Q1 2025, supported by strong subscription growth and increased stablecoin utility. Adjusted EBITDA reached $930 million, while the company also announced a major acquisition to boost its derivatives business.

• Generated $2.03 billion in total revenue and $66 million in net income.
• Adjusted EBITDA came in at $930 million, indicating strong operational efficiency.

CNRL delivered robust financial and operational performance, achieving record production and strong free cash flow, while also reducing its capital budget without affecting planned production.

• Revenue reached CAD 10.94 billion with significant growth across segments.
• Net income more than doubled year-over-year to CAD 2.46 billion.

The Trade Desk delivered robust results in Q1 2025, with 25% year-over-year revenue growth, high customer retention, and solid gains in both GAAP and non-GAAP profitability.

• Revenue grew 25% year-over-year to $616 million.
• GAAP Net Income was $51 million with a margin of 8%.

Sempra delivered strong Q1 2025 results with growth in both GAAP and adjusted earnings, driven by progress in infrastructure investments and solid performance across all business units.

• GAAP EPS rose to $1.39, with adjusted EPS at $1.44.
• Net income increased to $906 million, up from $801 million in Q1 2024.

Cheniere delivered solid Q1 2025 results, supported by stable LNG export volumes and higher margins. Net income fell from the prior year due to derivative impacts, but the company remains on track to meet its full-year guidance.

• Generated $5.44 billion in revenue and $353 million in net income.
• Shipped 168 LNG cargoes totaling 609 TBtu, a 1% increase YoY.

Monster Beverage Corporation reported a slight decrease in net sales for the first quarter of 2025 compared to the same period last year, totaling $1.85 billion. However, gross profit as a percentage of net sales improved to 56.5%, and operating income increased by 5.1%. Diluted earnings per share also saw a 7.4% increase to $0.45.

• Net sales for Q1 2025 were $1.85 billion, a 2.3% decrease from Q1 2024.
• Gross profit margin improved to 56.5% in Q1 2025, up from 54.1% in Q1 2024.

Cloudflare posted a robust Q1 2025 with $479.1 million in revenue and its highest net new ACV growth in three years, despite a GAAP net loss.

• Revenue grew to $479.1 million, driven by strong enterprise demand.
• Signed a $100M+ contract, the largest in company history, fueled by Workers platform.

Kenvue faced a 3.9% drop in net sales in Q1 2025, primarily due to a 2.7% foreign exchange impact and a 1.2% organic sales decline. Despite these challenges, the company improved its gross profit margin to 58.0%, increased operating income, and achieved higher diluted EPS year-over-year. The adjusted EPS and margins, however, declined slightly. Kenvue updated its FY2025 outlook to reflect tariff and currency pressures.

• Net sales declined 3.9% year-over-year to $3.741 billion, with a 1.2% drop in organic sales.
• Diluted EPS increased to $0.17 from $0.15 in Q1 2024; adjusted EPS declined to $0.24 from $0.28.

HubSpot delivered solid top-line performance in Q1 2025 with double-digit revenue growth, supported by increasing customer count and adoption of its AI-first offerings. The company posted a GAAP net loss but showed profitability on a non-GAAP basis.

• Total revenue reached $714,137,000, up from $617,414,000 in Q1 2024.
• GAAP net loss was $21,793,000, while non-GAAP net income reached $95,907,000.

argenx delivered robust revenue growth in Q1 2025 with product net sales reaching $790 million and reported a net profit of $169 million, reversing a loss from the previous year. Strong momentum in VYVGART launches and expansion supported commercial performance.

• Product net sales grew to $790 million, a 99% increase from Q1 2024.
• Reported net income reached $169 million, up from a loss of $62 million in Q1 2024.

Sun Life Financial reported solid first-quarter results, with underlying net income rising 19% year-over-year, supported by robust sales and operational strength in all geographies and business segments.

• Underlying net income rose to 1.045 billion CAD, up 170 million CAD from Q1 2024
• EPS reached 1.62 CAD; underlying EPS was 1.82 CAD

Wheaton Precious Metals achieved record financial results in Q1 2025, reporting $470 million in revenue and $361 million in operating cash flow, driven by higher realized gold prices and increased gold equivalent ounces sold. Adjusted net earnings and operating margins also rose significantly year-over-year.

• Revenue reached a record $470 million, up 58.5% YoY
• Operating cash flow surged to $361 million, a 64.5% increase

Franco-Nevada achieved its strongest quarter ever in Q1 2025, with $368.4 million in revenue and 126,585 GEOs sold. Elevated gold prices, increased contributions from new precious metal assets, and robust energy asset performance supported this record performance. The company maintained a high-margin business model, debt-free balance sheet, and expanded its portfolio with key acquisitions.

• Record revenue of $368.4 million, driven by high gold prices and increased production
• 126,585 GEOs sold, a 3% increase YoY

The bank posted R$44.5B in revenue and R$11.1B in net income, supported by growth in financial margins and improved efficiency.

• Recurring managerial net income reached R$11.1B, up from R$9.8B in Q1 2024.
• Operating revenues increased to R$44.5B, driven by a stronger financial margin with clients.

Cenovus delivered solid Q1 results with $859 million in net income and strong free cash flow of $983 million, supported by rising oil prices, increased upstream production, and improved U.S. refining margins.

• Net income reached $859 million, rebounding significantly from Q4 2024.
• Adjusted funds flow rose to $2.2 billion, indicating strong operational cash generation.

LPL Financial reported a strong start to 2025 with significant increases in net income, adjusted EPS, and gross profit compared to the prior year. Total advisory and brokerage assets also saw substantial growth, driven by both organic net new assets and acquisitions.

• Net Income was $319 million, up 11% year-over-year.
• Adjusted EPS increased 22% year-over-year to $5.15.

WBD posted a net loss of $453 million in Q1 2025, with revenue declining 10% year-over-year. Despite challenges in linear and studios businesses, streaming EBITDA saw strong improvement driven by subscriber and ad growth.

• Total revenue fell 10% YoY to $8.979 billion, driven by declines in advertising and content revenue.
• Net loss was $453 million, including $1.6 billion in pre-tax amortization and restructuring charges.

Pinterest delivered a robust quarter, achieving 16% year-over-year revenue growth and turning a profit with net income of $8.9 million. The platform reached a record 570 million global MAUs, while ARPU grew across all regions. Strong engagement and advertiser performance fueled the results.

• Revenue grew 16% year-over-year to $854,988,000.
• Global monthly active users reached a record 570 million.

Illumina reported first quarter 2025 Core Illumina revenue of $1.04 billion, a 1% decrease year-over-year. GAAP diluted EPS was $0.82 and non-GAAP diluted EPS was $0.97. The company updated its full-year 2025 financial guidance, reflecting anticipated impacts from geopolitical developments and tariffs, particularly affecting the Greater China region.

• Core Illumina revenue for Q1 2025 was $1.04 billion, a 1% decrease compared to Q1 2024.
• GAAP diluted EPS for Q1 2025 was $0.82, and non-GAAP diluted EPS was $0.97.

Toast delivered strong first-quarter performance driven by significant growth in ARR, profitability metrics, and expansion into enterprise accounts like Applebee’s and Topgolf.

• Net income reached $56 million, a turnaround from a loss of $83 million last year.
• Adjusted EBITDA more than doubled year-over-year to $133 million.

Natera reported strong first quarter 2025 results with significant growth in total revenue and product revenue, driven by increased test volume and improved average selling prices. The company also saw an increase in gross profit and managed its net loss.

• Total revenues increased by 36.5% to $501.8 million in Q1 2025 compared to $367.7 million in Q1 2024.
• Product revenues grew by 37.1% to $500.0 million in Q1 2025, up from $364.7 million in the prior year period.

Expedia Group reported first-quarter 2025 results, meeting top-line guidance with 4% bookings growth and 3% revenue growth year-over-year, while significantly exceeding bottom-line guidance through EBITDA margin expansion. The company also repurchased $330 million of shares in the quarter.

• Met top-line guidance with 4% bookings growth and 3% revenue growth year-over-year.
• Beat bottom-line guidance with EBITDA margin expansion.

Pembina Pipeline Corporation posted impressive first-quarter 2025 results, with revenue rising to $2.28 billion and adjusted EBITDA reaching $1.17 billion. Strong performance across all segments and strategic asset integration contributed to solid operating cash flow and financial growth, supporting an increased dividend.

• Revenue increased to $2.282 billion, a gain of $742 million YoY
• Adjusted EBITDA rose to $1.167 billion, up 12% from Q1 2024

Restaurant Brands International reported a decrease in total revenues and net income in the first quarter of 2025 compared to the previous year, primarily driven by an unfavorable FX impact and the absence of BK China revenues. However, Adjusted Operating Income saw a slight increase, and the company remains on track for 8%+ organic Adjusted Operating Income growth in 2025.

• Total Revenues decreased by 3.7% for Tim Hortons, increased by 1.8% for Burger King, increased by 9.0% for Popeyes, and increased by 7.9% for Firehouse Subs.
• Comparable Sales decreased by 0.1% for Tim Hortons, decreased by 1.3% for Burger King, and decreased by 4.0% for Popeyes.

DraftKings delivered a 20% revenue increase in Q1 2025 despite a net loss, fueled by user growth and improved Sportsbook performance.

• Revenue rose to $1.41 billion, up from $1.17 billion a year ago.
• Monthly Unique Payers reached 4.3 million, a 28% YoY increase.

Carlyle Group reported strong first-quarter 2025 results, with record Fee Related Earnings, FRE margin, and assets under management, reflecting focused execution and the strength of its global platform.

• Record Fee Related Earnings achieved in Q1 2025.
• Highest ever FRE margin reported.

Insulet delivered a strong first quarter in 2025, exceeding expectations with significant revenue growth driven by the Omnipod platform. The company also saw improvements in profitability metrics and raised its full-year guidance.

• Total revenue for Q1 2025 was $569.0 million, a 28.8% increase year-over-year.
• Total Omnipod revenue grew by 28.0% to $554.1 million.

Tapestry delivered strong results in the third quarter of fiscal 2025, with revenue increasing 7% and GAAP diluted EPS up 60% compared to the prior year. This performance was driven by robust growth in the Coach brand and expansion in gross and non-GAAP operating margins. The company also raised its full-year outlook for revenue, earnings, and cash flow.

• Achieved record third quarter revenue of $1.6 billion, a 7% increase year-over-year.
• Reported GAAP diluted EPS of $0.95, up 60% from the prior year.

US Foods reported a strong first quarter for fiscal year 2025, exceeding industry performance with growth in net sales, net income, and adjusted EBITDA. The company demonstrated consistent share gains with target customer types and announced a new $1 billion share repurchase program.

• Net Sales increased 4.5% to $9.4 billion.
• Net Income increased 40.2% to $115 million.

Warner Music Group reported a 1% decrease in total revenue (or 1% increase in constant currency) for the fiscal second quarter ended March 31, 2025. Net income decreased significantly by 63% to $36 million, while operating income saw a strong increase of 41% to $168 million. Adjusted OIBDA decreased 3% to $303 million.

• Total revenue decreased 1% to $1,484 million.
• Net income decreased 63% to $36 million.

News Corporation reported a 1% increase in revenues to $2.01 billion in the third quarter of fiscal 2025, compared to the prior year. Net income from continuing operations saw a significant 67% increase to $107 million, and Adjusted EPS rose to $0.17. The growth was primarily driven by strong performance in Dow Jones, Digital Real Estate Services, and Book Publishing.

• Third quarter revenues increased 1% to $2.01 billion.
• Net income from continuing operations rose 67% to $107 million.

SharkNinja delivered a 14.7% increase in net sales to $1.22 billion in Q1 2025, driven by growth across all product categories. While net income rose by 7.5%, adjusted profitability measures including EBITDA and net income declined year-over-year due to increased costs and tariff effects. The company raised its fiscal 2025 outlook, reflecting confidence in its mitigation strategies and operational strength.

• Net sales rose 14.7% to $1.22 billion, with strong performance across all product segments.
• Gross profit increased to $603.2 million, though gross margin slightly declined to 49.3%.

Alliant Energy began 2025 with EPS of $0.83 and net income of $213 million, outperforming internal targets despite negative temperature impacts. The company reaffirmed its earnings guidance and increased projected capital investments to support growing energy demands, including large-scale data centers.

• Reported GAAP EPS of $0.83, up from $0.62 in Q1 2024.
• Net income increased to $213 million, compared to $158 million in the prior year.

Akamai delivered a solid start to the year, meeting or exceeding expectations with first quarter revenue of $1.015 billion, up 3% year-over-year. Security and cloud computing revenue, representing 69% of total revenue, grew 10% year-over-year. Non-GAAP EPS was $1.70, up 4% year-over-year.

• First quarter revenue was $1.015 billion, a 3% increase year-over-year.
• Security revenue grew 8% year-over-year to $531 million.

Evergy, Inc. reported a net income of $128.1 million and diluted EPS of $0.54 for the three months ended March 31, 2025. This represents an increase from the same period in 2024, primarily due to new Evergy Missouri West retail rates, higher transmission revenues, and favorable weather, partially offset by higher interest and depreciation expense and lower investment earnings.

• Net income attributable to Evergy, Inc. increased to $125.0 million from $122.7 million in the prior year period.
• Diluted EPS increased to $0.54 from $0.53 in the prior year period.

Rocket Lab reported strong revenue growth in Q1 2025, driven by continued success in its launch and space systems segments. Despite a net loss, the company secured major defense contracts and laid out plans to reorganize under a new holding company structure.

• Revenue reached $123 million, hitting the high end of guidance.
• Net loss widened to $60.6 million, with an adjusted EBITDA loss of nearly $30 million.

EPAM delivered $1.302 billion in revenue and $2.41 non-GAAP EPS in Q1 2025, with strong organic growth leading to an upward revision of full-year revenue expectations.

• Revenue rose to $1.302 billion, an 11.7% increase year-over-year.
• GAAP operating income was $99.3 million; non-GAAP operating income reached $175.8 million.

Royalty Pharma delivered a robust first quarter in 2025, with Portfolio Receipts growing 17% to $839 million and Royalty Receipts increasing 12% to $788 million. The company repurchased $723 million in Class A ordinary shares and raised its full-year 2025 guidance for Portfolio Receipts.

• Portfolio Receipts grew 17% to $839 million, demonstrating strong financial performance.
• Royalty Receipts increased 12% to $788 million, primarily due to strong performance from the cystic fibrosis franchise, Trelegy, and Xtandi.

Insmed delivered strong revenue growth for ARIKAYCE in Q1 2025 across all regions, while advancing key clinical programs and preparing for the potential launch of brensocatib later in the year.

• ARIKAYCE global revenue rose 23% year-over-year to $92.8 million.
• Net loss increased to $256.6 million, or $1.42 per share.

Viatris delivered total revenues in line with expectations, demonstrating strength in its base business. The company made significant pipeline progress with three positive Phase 3 data readouts and returned more than $450 million in capital to shareholders year-to-date, reaffirming its 2025 capital allocation priorities. Despite a U.S. GAAP net loss driven by a goodwill impairment charge, adjusted net earnings and adjusted EBITDA were positive.

• Total revenues for Q1 2025 were $3.3 billion, a decrease of 11% reported and 2% on a divestiture-adjusted operational basis compared to Q1 2024.
• U.S. GAAP net loss was $3.0 billion, primarily due to a $2.9 billion goodwill impairment charge.

Lamar Advertising posted $505.4 million in revenue and a $139.2 million net income in Q1 2025, with net income growth primarily due to the $67.7 million gain from the Vistar Media stake sale, while Adjusted EBITDA slightly declined.

• Net revenues rose 1.5% year-over-year to $505.4 million.
• Net income increased 77.4% to $139.2 million due to the Vistar Media gain.

Solventum achieved 4.3% organic sales growth in Q1 2025, driven by strong performance in MedSurg and Health Information Systems. Despite the increase in revenue, net income and operating income fell sharply year-over-year due to higher costs and margin pressures. Free cash flow turned negative, reflecting investment and operating dynamics post-spin-off.

• Revenue reached $2.07 billion, growing 2.6% overall and 4.3% organically.
• Net income declined to $137 million from $237 million in Q1 2024.

Globus Medical reported a slight decrease in net sales for Q1 2025 compared to the prior year, primarily due to softer Enabling Technology sales and international order timing, offset by strength in the US spine business. The company achieved GAAP net income and positive GAAP and non-GAAP EPS, alongside record Q1 free cash flow and a return to debt-free status.

• Worldwide net sales decreased by 1.4% to $598.1 million in Q1 2025.
• GAAP net income was $75.5 million for the quarter.

Texas Roadhouse reported a modest increase in net income and diluted earnings per share in the first quarter of 2025, driven by higher sales and share repurchases, despite facing challenges from commodity and labor inflation.

• Total revenue increased by 9.6% to $1.448 billion compared to the prior year.
• Diluted earnings per share increased by 1.0% to $1.70.

Molson Coors' Q1 2025 saw declines in net sales, operating income, and net income, primarily due to lower financial volumes and cost inflation, despite favorable pricing and brand mix strategies.

• Net sales fell to $2.304 billion, down 11.3% from the prior year.
• GAAP net income dropped to $121.0 million, with EPS at $0.59.

TKO reported Q1 2025 revenue of $1.269 billion, driven by double-digit growth at UFC and WWE. Net income surged to $165.5 million, reversing a loss in the prior year, and free cash flow climbed significantly. The company raised full-year guidance and included the impact of new acquisitions, reflecting positive momentum across its diversified sports and entertainment portfolio.

• Revenue reached $1.269 billion, up 4% YoY, driven by growth at UFC and WWE.
• Net income turned positive at $165.5 million, reversing a $234.5 million loss last year.

Aurora began commercial driverless trucking operations in Q1 2025, completed over 4,000 driverless miles, and maintained strong fiscal discipline while preparing for expansion.

• Launched regular driverless freight operations between Dallas and Houston on April 27, 2025.
• Achieved 100% Autonomy Readiness Measure (ARM) and 95% 100% API performance on production loads.

Dropbox announced financial results for the first quarter ended March 31, 2025, reporting a slight decrease in revenue and ARR year-over-year, while GAAP and Non-GAAP net income and operating margins increased.

• Total revenue decreased 1.0% year-over-year to $624.7 million.
• Total ARR decreased 0.2% year-over-year to $2.552 billion.

BILL reported strong financial performance in Q3 FY2025, with total revenue increasing 11% year-over-year and core revenue increasing 14%. The company exceeded non-GAAP profitability expectations and expanded its platform and distribution ecosystem.

• Total revenue for Q3 FY2025 was $358.2 million, an 11% increase year-over-year.
• Core revenue, consisting of subscription and transaction fees, grew 14% year-over-year to $320.3 million.

Molson Coors' Q1 2025 saw declines in net sales, operating income, and net income, primarily due to lower financial volumes and cost inflation, despite favorable pricing and brand mix strategies.

• Net sales fell to $2.304 billion, down 11.3% from the prior year.
• GAAP net income dropped to $121.0 million, with EPS at $0.59.

Onto Innovation achieved record quarterly revenue of $267 million in Q1 2025, driven by significant growth in advanced nodes. The company also reported strong GAAP and non-GAAP financial results, including record cash from operations.

• Record quarterly revenue of $267 million, marking the seventh consecutive quarter of growth.
• Advanced nodes revenue doubled quarter-over-quarter, showing strength in leading-edge DRAM, NAND, and gate-all-around devices.

Match Group delivered $831M in revenue and $117.6M in net income in Q1 2025. Despite a 3% YoY revenue decline, the company emphasized operational discipline and accelerated product development under new CEO leadership.

• Revenue declined 3% YoY to $831M, with a 5% drop in payers offset slightly by higher RPP.
• Net income reached $117.6M and operating income was $173M, down 7% YoY.

Planet Fitness reported a strong first quarter for 2025, with total revenue increasing by 11.5% and system-wide same club sales growing by 6.1%. The company also saw an increase in total membership and adjusted EBITDA, while repurchasing $50.0 million in shares.

• Total revenue increased by 11.5% to $276.7 million compared to the prior year period.
• System-wide same club sales increased by 6.1%.

Trex delivered strong Q1 2025 performance with $340 million in revenue and $60 million in net income, boosted by demand for premium and new products, while maintaining strategic investments in innovation and distribution.

• Q1 2025 revenue reached $340 million, exceeding guidance despite a YoY decline due to prior-year channel inventory.
• Net income was $60 million with EPS of $0.56; adjusted EPS was $0.60.

The company delivered solid financial results in Q1 2025 with a 6 cent increase in EPS year-over-year, a strong FFO of $1.70 per share, and increased occupancy and leasing activity.

• Net income available for common shareholders was $61.8 million, or $0.72 per diluted share.
• Funds from operations (FFO) reached $146.5 million, or $1.70 per diluted share.

Paramount delivered a profitable quarter supported by subscriber growth in Paramount+, strong engagement metrics, and a rebound in Filmed Entertainment led by Sonic the Hedgehog 3. Despite a revenue dip driven by Super Bowl comparison effects, operational improvements led to positive net income and cash flow.

• Paramount+ grew to 79 million subscribers with improved churn and engagement.
• Net income reached $152 million, reversing last year’s loss.

Stevanato Group reported a 9% increase in revenue for the first quarter of 2025, reaching €256.6 million, primarily driven by strong performance in the Biopharmaceutical and Diagnostic Solutions segment. Gross profit and operating profit margins also improved. The company maintained its full-year revenue guidance but lowered its adjusted EBITDA and adjusted diluted EPS guidance to reflect the estimated impact of recently announced tariffs.

• Revenue increased by 9% to €256.6 million in Q1 2025 compared to the prior year.
• The Biopharmaceutical and Diagnostic Solutions segment saw 11% revenue growth, offsetting a decline in the Engineering segment.

Nova delivered an outstanding first quarter, with record revenue of $213.4M and strong profitability, driven by increasing adoption of metrology solutions in advanced semiconductor processes.

• Revenue hit an all-time high at $213.4M, up 50% YoY.
• GAAP net income reached $64.8M, exceeding company guidance.

Americold reported a decrease in total revenues and a net loss for the first quarter of 2025 compared to the prior year, primarily due to lower volumes in the warehouse segment and decreased transportation services revenue. Despite this, the company increased its quarterly dividend by 5% and completed a strategic acquisition.

• Total revenues decreased by 5.4% to $629.0 million in Q1 2025.
• The company reported a net loss of $16.5 million, or $0.06 per diluted share, in Q1 2025.

Post Holdings generated $2.0 billion in revenue and $62.6 million in net income in Q2 2025, with strong segment performance in Foodservice and Weetabix partially offsetting declines in Consumer Brands and Refrigerated Retail; Adjusted EBITDA reached $346.5 million.

• Net sales reached $1.95 billion, down 2.3% YoY, impacted by category declines and timing shifts.
• Net income was $62.6 million with Adjusted EBITDA of $346.5 million.

The company posted a net loss of over $533 million due to a $510 million loss on the fair value of digital assets, despite achieving a 30% year-over-year revenue increase and improvements in mining efficiency and hashrate.

• Revenue rose 30% YoY to $213.9 million due to a higher bitcoin price.
• Reported a net loss of $533.4 million largely due to fair value losses on digital assets.

Life Time Group Holdings, Inc. reported a strong first quarter for 2025, with total revenue reaching $706.0 million, an 18.3% increase year-over-year. Net income surged by 205.6% to $76.1 million, and adjusted EBITDA increased by 31.2% to $191.6 million, driven by increased member engagement and effective cost management.

• Total revenue increased 18.3% to $706.0 million, driven by strong growth in membership dues and in-center revenue.
• Net income increased 205.6% to $76.1 million, primarily due to improved business performance and a tax benefit from stock option exercises.

Crocs, Inc. delivered a resilient Q1 2025 performance with stable revenues and improved earnings, supported by higher margins and robust brand demand despite a volatile macroeconomic environment.

• Total revenue was $937,333,000, nearly flat compared to the prior year.
• Adjusted EPS held strong at $3.00, with GAAP EPS at $2.83.

Lincoln National Corporation reported a net loss of $722 million for the first quarter of 2025, or $(4.41) per diluted share. However, adjusted operating income available to common stockholders was $280 million, or $1.60 per diluted share, showing a 14% year-over-year increase. The company highlighted strong execution against strategic and financial objectives, including increased Group Protection earnings and significant Annuities sales.

• Adjusted operating income increased 14% year-over-year.
• Group Protection earnings were up 26% year-over-year, with operating margin improving by 120 basis points.

Lyft delivered a profitable Q1 with net income of $2.6 million, boosted by record rides and active rider numbers. The company also generated significant free cash flow and increased its share repurchase program.

• Achieved net income of $2.6 million, reversing a loss from the previous year.
• Recorded $4.16 billion in Gross Bookings, up from $3.69 billion YoY.

Installed Building Products, Inc. reported a net revenue of $684.8 million for the first quarter of 2025, a 1.2% decrease from the prior year. Net income decreased to $45.4 million, and diluted EPS was $1.64. The company maintained strong operating cash flow and continued its capital allocation initiatives, including share repurchases and dividends.

• Net revenue decreased by 1.2% to $684.8 million in Q1 2025 compared to Q1 2024.
• Net income for Q1 2025 was $45.4 million, down from $55.9 million in Q1 2024.

AMG reported Economic Earnings per share of $5.20 in the first quarter of 2025, reflecting the ongoing evolution of its business and the positive impact of its disciplined capital allocation strategy. The company announced three new partnerships in alternative strategies and repurchased approximately $173 million in common stock.

• Reported Economic Earnings per share of $5.20 for the first quarter of 2025.
• Announced three new partnerships in alternative strategies: Verition Fund Management, Qualitas Energy, and NorthBridge Partners.

ACI Worldwide delivered strong Q1 2025 results, exceeding expectations with a 25% increase in revenue and a shift from a net loss to a significant net income. The Payment Software segment showed exceptional growth, and the company raised its full-year 2025 guidance.

• Revenue increased by 25% to $395 million compared to Q1 2024.
• Net income was $59 million in Q1 2025, a significant improvement from a net loss of $8 million in Q1 2024.

Main Street Capital reported a strong first quarter in 2025, with net investment income of $89.8 million, total investment income of $137.0 million, and a net increase in net assets resulting from operations of $116.1 million. The company also achieved a record net asset value per share of $32.03 and maintained a low operating expenses to assets ratio.

• Net investment income remained consistent at $89.8 million compared to the prior year, resulting in $1.01 per share.
• Total investment income increased by 4% to $137.0 million, primarily driven by a significant increase in dividend income.

SoundHound AI saw record Q1 2025 results, with revenue surging 151% year-over-year to $29.1 million and a GAAP net income of $129.9 million driven by mark-to-market gains. However, the company posted a non-GAAP net loss and continued investment in product and partnership expansion.

• Revenue grew 151% YoY to $29.1 million, marking a record quarter.
• GAAP net income was $129.9 million, boosted by a $176 million gain from contingent acquisition liabilities.

Nexstar Media Group delivered solid first quarter results, driven by record distribution revenue and disciplined expense management. The company reported net revenue of $1.23 billion, net income of $97 million, and adjusted EBITDA of $381 million. Despite a decrease in political advertising revenue, distribution revenue saw a slight increase, and the company continued its strategic initiatives including debt repayment, dividends, and stock repurchases.

• Net Revenue for Q1 2025 was $1.23 billion, a decrease of 3.9% year-over-year.
• Net Income for Q1 2025 was $97 million, a decrease of 41.9% compared to the prior year quarter.

Valvoline Inc. reported second quarter fiscal year 2025 results with sales of $403 million, a 4% increase, and system-wide store sales growth of 11% to $826 million. Reported income from continuing operations and EPS declined, while adjusted EBITDA and Adjusted EPS also saw declines, primarily due to the impact of refranchising. The company added 33 net new stores during the quarter and reiterated its full-year guidance.

• Sales of $403 million grew 4% year-over-year.
• System-wide store sales grew 11% to $826 million.

Six Flags Entertainment Corporation announced its first quarter 2025 results, with net revenues totaling $202 million and a net loss of $220 million. The results were significantly impacted by the merger with legacy Cedar Fair, which closed on July 1, 2024, and the seasonal nature of the business, with most parks closed during the quarter. Despite weather challenges, the combined company saw a 1% increase in attendance in April.

• Net revenues for Q1 2025 totaled $202 million, with $111 million contributed by legacy Six Flags operations.
• The company reported a net loss of $220 million, or $2.20 per diluted share, for Q1 2025.

American Healthcare REIT, Inc. reported a GAAP net loss of $(6.8) million for the first quarter of 2025, or $(0.04) per diluted share. Despite a challenging winter, the company achieved strong Same-Store Net Operating Income (NOI) growth of 15.1% across its total portfolio, driven by robust performance in its Integrated Senior Health Campuses (ISHC) and Senior Housing Operating Properties (SHOP) segments. The company also successfully raised capital through its ATM program and increased its full-year 2025 guidance for both Same-Store NOI growth and Normalized Funds from Operations (NFFO).

• Reported GAAP net loss attributable to controlling interest of $(6.8) million and GAAP net loss attributable to common stockholders of $(0.04) per diluted share for the three months ended March 31, 2025.
• Achieved total portfolio Same-Store Net Operating Income (NOI) growth of 15.1% for the three months ended March 31, 2025, compared to the same period in 2024.

Maximus reported a solid second quarter for fiscal year 2025 with revenue increasing by 1.0% to $1.36 billion. Diluted EPS and adjusted diluted EPS saw significant increases compared to the prior year period. The company is raising its full-year fiscal year 2025 guidance for both revenue and earnings.

• Revenue increased 1.0% to $1.36 billion, driven by organic growth of 3.0% in the U.S. Federal Services Segment.
• Diluted earnings per share increased to $1.69 and adjusted diluted earnings per share rose to $2.01.

Ingram Micro Holding Corporation delivered a strong fiscal first quarter 2025, with net sales reaching $12.281 billion, an 8.3% increase from the prior year, and diluted earnings per share of $0.29, aligning with the high end of their guidance. The company also reported a non-GAAP net income of $144.2 million.

• Net sales increased by 8.3% year-over-year to $12.281 billion, exceeding guidance.
• Diluted EPS was $0.29, and non-GAAP diluted EPS was $0.61, both at the high end of guidance.

Sensata Technologies reported a strong first quarter for 2025 with revenue of $911.3 million, operating income of $122.2 million, and diluted EPS of $0.47. Adjusted operating income was $166.5 million and adjusted EPS was $0.78. The company generated $86.6 million in free cash flow and returned $118.4 million to shareholders through share repurchases and dividends.

• Revenue for Q1 2025 was $911.3 million, a decrease of 9.5% compared to Q1 2024.
• Operating income was $122.2 million, representing a 13.4% operating margin.

Allegro MicroSystems reported Q4 fiscal year 2025 results with sales of $193 million, an 8% sequential increase, but a 20% decrease year-over-year. Non-GAAP EPS was $0.06.

• Fourth Quarter Sales increased 8% sequentially to $193 million.
• GAAP diluted EPS for Q4 2025 was $(0.08).

ICU Medical reported improved results in the first quarter of 2025 compared to the prior year, with increased total revenues, gross profit, and a significantly reduced net loss. Adjusted EBITDA and adjusted diluted EPS also showed strong growth.

• Total revenues for Q1 2025 increased to $604.7 million from $566.7 million in Q1 2024.
• GAAP gross profit rose to $210.1 million in Q1 2025 from $185.2 million in the prior year period.

Victory Capital reported strong first-quarter results for 2025, with increases in revenue, Adjusted EBITDA, Adjusted EBITDA margin, and earnings per share compared to the same quarter last year. Gross sales and net long-term flows also showed improvement from the previous quarter. The company's AUM decreased slightly due to negative market action and net outflows.

• Revenue increased by 1.7% year-over-year to $219.6 million in Q1 2025.
• GAAP operating margin expanded to 42.3% in Q1 2025, up from 39.3% in Q1 2024.

CarGurus reported strong first-quarter 2025 results, with total revenue growing 4% year-over-year, driven by a 13% increase in Marketplace revenue. GAAP Net Income saw a significant increase of 83%, and Non-GAAP Adjusted EBITDA was up 32% year-over-year. The company also repurchased a substantial amount of shares.

• Marketplace revenue increased by 13% year-over-year in Q1 2025.
• GAAP Net Income for Q1 2025 was $39.0 million, an 83% increase compared to the prior year.

Nelnet reported a strong start to 2025 with GAAP net income increasing to $82.6 million, or $2.26 per share, compared to $73.4 million, or $1.98 per share, in the prior year. Net income, excluding derivative market value adjustments, also saw a significant increase to $87.4 million. The company's core businesses performed well, contributing to overall momentum and allowing for strategic investments.

• GAAP net income increased to $82.6 million, up from $73.4 million in the prior year's first quarter.
• Non-GAAP net income, excluding derivative market value adjustments, rose to $87.4 million from $67.4 million.

Super Group announced strong first quarter 2025 unaudited consolidated financial results, with revenue reaching a record $517 million, a 25% year-over-year increase. Adjusted EBITDA increased by 120% to $111.1 million. The company also reported a profit of $59.4 million for the period.

• Revenue increased by 25% to $516.8 million for Q1 2025, driven by growth in Africa, Europe, and North America.
• Profit for the period was $59.4 million for Q1 2025, up from $44.6 million in Q1 2024.

Prestige Consumer Healthcare Inc. delivered another year of consistent sales and earnings per share growth, with record fourth quarter sales performance driven by International business strength, growth in various categories and brands in North America, and success in eCommerce.

• Record reported revenues in Q4 fiscal 2025 of $296.5 million, a 7.0% increase from the prior year.
• Organic revenue grew 7.9% in Q4, reflecting broad-based growth across North America and International business segments.

Dentsply Sirona reported a decrease in net sales for Q1 2025, driven by a decline in the United States and Orthodontic and Implant Solutions segment. Despite the sales challenges, the company saw improvements in adjusted EBITDA margin and maintained its full-year adjusted EPS outlook.

• Net sales for Q1 2025 were $879 million, a decrease of 7.7% compared to Q1 2024.
• GAAP net income was $20 million, or $0.10 per share, a slight increase from $18 million or $0.09 per share in Q1 2024.

Compass achieved record Q1 free cash flow and Adjusted EBITDA, with significant revenue growth driven by increased transactions and market share gains. The company's strategic acquisitions contributed to top-line expansion while operating expenses remained controlled.

• Revenue in Q1 2025 increased by 28.7% year-over-year to $1.4 billion.
• Adjusted EBITDA was $15.6 million in Q1 2025, a $35.7 million improvement year-over-year.

ALLETE reported first quarter 2025 net income of $56.1 million, or 97 cents per share, compared to $50.7 million, or 88 cents per share, in the prior year period. Results were impacted by lower industrial margins at Minnesota Power, partially offset by strong performance from non-regulated subsidiaries ALLETE Clean Energy and New Energy Equity.

• Q1 2025 net income attributable to ALLETE was $56.1 million ($0.97 per share), up from $50.7 million ($0.88 per share) in Q1 2024.
• Regulated Operations net income decreased to $38.4 million from $44.2 million due to lower industrial margins at Minnesota Power.

Alight reported a decrease in revenue for the first quarter of 2025 compared to the prior year, primarily due to lower project revenue and net commercial activity. Despite this, the company saw improvements in net loss and Adjusted EBITDA, benefiting from reduced expenses and lower interest payments. Alight reaffirmed its full-year 2025 financial outlook, citing a strong amount of projected revenue already under contract.

• Revenue decreased by 2.0% to $548 million in Q1 2025.
• Net loss improved significantly to $17 million compared to a $121 million net loss in Q1 2024.

Tecnoglass delivered an exceptional first quarter in 2025, achieving record revenue of $222.3 million, a 15.4% increase year-over-year, driven by strong organic growth in both residential and multi-family/commercial segments. The company also reported significant improvements in gross margin and Adjusted EBITDA, alongside a record cash position.

• Achieved record first quarter revenue of $222.3 million, up 15.4% year-over-year.
• Delivered strong gross margin of 43.9%, a 510 basis point improvement compared to the prior year.

Griffon reported a decrease in revenue and net income for the second quarter of fiscal 2025 compared to the prior year, driven by lower volume in both segments. Adjusted EBITDA also declined. Home and Building Products saw reduced revenue and EBITDA due to decreased volume and higher costs, while Consumer and Professional Products experienced a revenue decline but an increase in Adjusted EBITDA, benefiting from global sourcing and strong performance in Australia.

• Total revenue decreased 9% to $611.7 million compared to the prior year quarter.
• Net income totaled $56.8 million, or $1.21 per diluted share, down from $64.1 million, or $1.28 per diluted share.

EPR Properties delivered solid earnings growth in the first quarter of 2025, driven by increased revenue from rental, mortgage, and other financing income. The company reported strong AFFO per diluted common share growth and increased its full-year guidance for FFOAA per diluted common share, while maintaining a strong liquidity position.

• Total revenue increased by 4.7% year-over-year for the first quarter of 2025.
• AFFO per diluted common share grew by 8.0% to $1.21 compared to $1.12 in the prior year quarter.

Adtalem Global Education reported strong third quarter fiscal year 2025 results, with significant growth in revenue and earnings per share, driven by increased student enrollment across its institutions. The company also raised its full-year guidance, reflecting continued positive momentum.

• Total student enrollment increased by 9.8% year-over-year, reaching 94,223.
• Revenue grew by 12.9% year-over-year to $466.1 million.

Cogent Communications reported service revenue of $247.0 million for Q1 2025, a 2.1% decrease from Q4 2024 and a 7.2% decrease from Q1 2024. The company experienced a net loss of $52.0 million for the quarter. Despite the revenue decline, Cogent increased its regular quarterly dividend to $1.01 per share.

• Service revenue for Q1 2025 was $247.0 million, a decrease of 2.1% sequentially and 7.2% year-over-year.
• Net loss for Q1 2025 was $52.0 million, compared to $43.3 million in Q4 2024 and $65.3 million in Q1 2024.

MDU Resources Group, Inc. delivered a strong start to the first quarter of 2025, with net income of $82.0 million and diluted earnings per share of $0.40. The pipeline segment reported record earnings, up 13.9%, and natural gas distribution earnings increased by 11.5%, contributing to the company's momentum as a pure-play regulated energy delivery business.

• Pipeline segment reported record first quarter earnings, up 13.9% to $17.2 million.
• Natural gas distribution earnings increased by 11.5% to $44.7 million.

Haemonetics delivered solid earnings growth in fiscal 2025, with record margin expansion and strong cash flow, driven by the performance of NexSys, TEG, and VASCADE technologies. The company is on track to achieve its four-year long-range plan goals for fiscal 2026.

• Fourth quarter fiscal 2025 revenue was $330.6 million, a decrease of 3.7% compared to the prior year.
• Net income for the fourth quarter fiscal 2025 was $58.0 million, an increase of 184.7% compared to the prior year.

Crinetics Pharmaceuticals reported a net loss of $96.8 million for Q1 2025, compared to $66.9 million in Q1 2024. Revenues were $0.4 million, down from $0.6 million in the prior year. The company maintains a strong cash position of $1.3 billion, projected to fund operations into 2029.

• Paltusotine's New Drug Application (NDA) for acromegaly is on track with productive FDA engagement, with a PDUFA date of September 25, 2025.
• The CALM-CAH Phase 3 study for atumelnant in congenital adrenal hyperplasia (CAH) is set to initiate with an uncompromising primary endpoint to normalize androstenedione levels.

MP Materials delivered strong execution in Q1 2025 with a 25% increase in total revenue year over year, driven by higher production and sales volumes of separated rare earth products, particularly NdPr oxide and metal. The company also began recognizing revenue from its new Magnetics division.

• Total revenue increased 25% year over year to $60.8 million.
• Record NdPr production of 563 metric tons, a 36% sequential increase.

Sweetgreen reported a 5.4% increase in total revenue for the first quarter of fiscal year 2025, reaching $166.3 million. Despite a negative same-store sales change of 3.1%, driven by decreased traffic, the company saw an increase in net new restaurant openings and maintained a restaurant-level profit margin of 17.9%. Net loss decreased slightly to $(25.0) million.

• Total revenue increased by 5.4% to $166.3 million.
• Restaurant-Level Profit Margin was 17.9%, a decrease of 20 basis points year-over-year.

Globalstar reported a 6% increase in first-quarter 2025 revenue, reaching $60.0 million, primarily driven by wholesale capacity services. The company posted a net loss of $17.3 million and an Adjusted EBITDA of $30.4 million. Globalstar also launched a two-way satellite commercial IoT solution and reiterated its full-year 2025 financial guidance.

• Total revenue for Q1 2025 was $60.0 million, a 6% increase from the prior year.
• Net loss for the quarter was $17.3 million.

DoubleVerify reported a strong start to 2025 with first-quarter revenue of $165.1 million, a 17% increase year-over-year, and adjusted EBITDA of $44.7 million, representing a 27% margin. Growth was driven by broad adoption of verification and activation solutions, new enterprise customers, and momentum in supply-side business.

• Total revenue increased by 17% year-over-year to $165.1 million.
• Activation revenue grew by 20% and Supply-Side revenue increased by 35% year-over-year.

AvePoint delivered a robust first quarter in 2025, with total revenue increasing by 25% year-over-year to $93.1 million and SaaS revenue growing by 34%. The company achieved GAAP operating income of $3.3 million, a significant improvement from a loss in the prior year, and non-GAAP operating income of $13.4 million, demonstrating strong operational efficiency.

• Total revenue for Q1 2025 reached $93.1 million, a 25% increase from the first quarter of 2024.
• SaaS revenue grew by 34% year-over-year to $68.9 million, contributing significantly to overall revenue growth.

Rumble reported a significant increase in revenue for Q1 2025, reaching $23.7 million, up 34% year-over-year. The company also saw a substantial improvement in net loss, reducing it to $2.7 million from $43.3 million in the prior year. MAUs were 59 million, reflecting strong retention post-election.

• Revenue for the first quarter increased by 34% year-over-year to $23.7 million.
• Net loss for the first quarter significantly improved to $2.7 million from $43.3 million in the prior year.

Prospect Capital Corporation reported a net loss applicable to common shareholders of $171.3 million for the quarter ended March 31, 2025, a significant decrease from the net income of $113.9 million in the same period last year. Net investment income also declined to $83.5 million from $94.4 million year-over-year. Total assets decreased to $7.0 billion from $7.9 billion.

• Net Investment Income decreased to $83.5 million compared to $94.4 million in the prior year quarter.
• Net Loss Applicable to Common Shareholders was $171.3 million, down from a Net Income of $113.9 million in the same quarter last year.

YETI saw a 3% revenue increase and a 5% boost in net income in Q1 2025. While EPS improved, adjusted EPS declined due to FX impacts. Coolers & Equipment drove segment growth, while Drinkware declined amid supply chain shifts.

• Revenue rose 3% year-over-year to $351,128,000, despite a 100bps FX headwind.
• EPS increased 11% to $0.20, but adjusted EPS fell 9% to $0.31 due to FX impact.

First Advantage reported strong financial performance in Q1 2025, exceeding expectations with revenues of $354.6 million, a significant increase from the prior year, driven by the Sterling acquisition. The company reported a net loss due to acquisition-related expenses and depreciation and amortization, but achieved positive adjusted net income and adjusted EBITDA, reaffirming its full-year guidance.

• Revenues for Q1 2025 were $354.6 million, a substantial increase compared to $169.4 million in Q1 2024.
• Net loss was $(41.2) million, including significant expenses related to the Sterling acquisition and integration.

Synaptics delivered a solid third quarter of fiscal 2025 with revenues increasing 12% year-over-year, driven by strong growth in Core IoT products. The company reported a GAAP net loss but a positive non-GAAP net income and generated significant cash flow from operations.

• Third quarter fiscal 2025 revenue was $266.6 million, a 12% increase year-over-year.
• Core IoT product sales grew 43% year-over-year and accounted for 25% of total sales.

RingCentral reported a solid start to 2025 with Q1 results demonstrating continued leadership in UCaaS and strong momentum in CCaaS. Total revenue reached $612 million, at the high end of guidance, driven by 6% year-over-year growth in subscriptions revenue. The company achieved GAAP operating profitability for the third consecutive quarter and exceeded $2.5 billion in ARR. Non-GAAP operating margin also exceeded guidance, and the company generated record free cash flow of $130 million.

• Total revenue for Q1 2025 was $612 million, up 5% year-over-year.
• Subscriptions revenue grew 6% year-over-year to $590 million, representing 96% of total revenue.

Warby Parker delivered a strong start to 2025, achieving positive net income for the first time as a public company. Revenue grew by 11.9% year-over-year, driven by increased active customers and average revenue per customer. The company also saw significant growth in Adjusted EBITDA and Free Cash Flow, while opening 11 net new stores.

• Net revenue increased 11.9% to $223.8 million.
• Achieved GAAP net income of $3.5 million, their first profitable quarter as a public company.

PENN Entertainment reported increased revenues, net income, Adjusted EBITDA, and Adjusted EBITDAR for the first quarter of 2025 compared to the same period in 2024. The company's properties showed resilience despite weather challenges, and the Interactive segment achieved record gaming revenue and improved year-over-year results despite unfavorable sports betting hold.

• Revenues increased to $1.67 billion, up from $1.61 billion in the prior year.
• Net income was $111.5 million, a significant improvement from a net loss of $114.9 million in Q1 2024.

OUTFRONT Media reported first quarter 2025 results with revenues of $390.7 million, a decrease of 4.4% compared to the same prior-year period. The company posted a net loss attributable to OUTFRONT Media Inc. of $20.6 million. Adjusted OIBDA was $64.2 million and AFFO attributable to OUTFRONT Media Inc. was $23.9 million.

• Revenues decreased by 4.4% to $390.7 million in Q1 2025 compared to Q1 2024.
• Net loss attributable to OUTFRONT Media Inc. improved to $20.6 million from $27.2 million in the prior year.

Alarm.com's first quarter 2025 results showed strong growth, with total revenue increasing 7.0% year-over-year to $238.8 million and GAAP net income rising 18.4% to $27.7 million. SaaS and license revenue also grew 9.0% to $163.8 million, and non-GAAP adjusted EBITDA increased 17.5% to $43.5 million.

• SaaS and license revenue increased 9.0% to $163.8 million compared to the first quarter of 2024.
• Total revenue increased 7.0% to $238.8 million compared to the first quarter of 2024.

HanesBrands Inc. delivered a strong first quarter in 2025, exceeding expectations with increased revenue, operating profit, and earnings per share. The company's growth strategy and transformation initiatives contributed to these positive results. Full-year guidance was reiterated, reflecting the expected impacts from U.S. tariffs, which the company aims to mitigate through cost reductions and pricing actions.

• Net Sales increased 2.1% over the prior year to $760 million, remaining consistent on an organic constant currency basis.
• GAAP Operating Profit surged by 126% to $80 million, with GAAP Operating Margin increasing 575 basis points to 10.5%.

Vericel reported record first quarter MACI and total revenue, driven by continued strength in MACI Arthro launch. The company reaffirmed full-year revenue guidance and raised profitability guidance.

• Total net revenue for the first quarter of 2025 was $52.6 million, an increase from $51.3 million in the prior year.
• MACI net revenue grew by 15% to $46.3 million, representing a record first quarter for the product.

TEGNA reported a 5% decrease in total revenue for the first quarter of 2025, primarily due to lower political advertising revenue and advertising and marketing services revenue. Despite this, the company achieved its key guidance metrics for the quarter and reaffirmed its two-year Adjusted Free Cash Flow guidance.

• Total company revenue decreased 5% to $680 million, in line with guidance.
• GAAP operating income totaled $109 million, a decrease of 21% year-over-year.

Zai Lab reported a 22% year-over-year increase in total revenues for the first quarter of 2025, reaching $106.5 million. Operating loss improved significantly, declining 20% year-over-year. The company remains on track to achieve profitability in the fourth quarter of 2025.

• Total revenues grew 22% year-over-year to $106.5 million in Q1 2025.
• Operating loss improved by 20% year-over-year to $56.3 million.

CleanSpark reported significant revenue growth in Q2 2025, reaching $181.7 million, a 62.5% increase year-over-year, driven by strong Bitcoin production. Despite this, the company posted a net loss of $138.8 million.

• Quarterly revenues were $181.7 million, a 62.5% increase from the prior year.
• Net loss for the quarter was $138.8 million, or ($0.49) per basic share.

Innospec Inc. announced its financial results for the first quarter ended March 31, 2025, with total revenues of $440.8 million, a 12% decrease from the prior year. Net income was $32.8 million, or $1.31 per diluted share, and adjusted non-GAAP EPS was $1.42. The company generated $28.3 million in cash from operations and increased its semi-annual dividend by 10% to 84 cents per common share.

• Total revenues for Q1 2025 were $440.8 million, a 12% decrease year-over-year.
• Net income for the quarter was $32.8 million, or $1.31 per diluted share.

Hub Group reported first quarter 2025 results with diluted earnings per share of $0.44, matching the prior year. Revenue for the quarter was $915 million, an 8% decrease from the prior year. Operating income improved to $37 million, representing 4.1% of revenue.

• Diluted earnings per share was $0.44, consistent with the first quarter of 2024.
• First quarter revenue decreased 8% to $915 million compared to $999 million in the prior year.

Diodes Incorporated reported first-quarter fiscal 2025 results, exceeding revenue expectations with $332.1 million, a 10% increase year-over-year. Despite a GAAP net loss of $4.4 million, non-GAAP adjusted net income was $8.8 million. The company saw improving market conditions in key segments and is guiding for continued year-over-year growth in the second quarter.

• Revenue for Q1 2025 was $332.1 million, a 10% increase compared to $302.0 million in Q1 2024.
• The company reported a GAAP net loss of $4.4 million, or $0.10 per diluted share, compared to GAAP net income of $14.0 million, or $0.30 per diluted share, in Q1 2024.

Privia Health reported strong first quarter 2025 financial results with significant growth in total revenue, net income, and Adjusted EBITDA compared to the same period last year. The company also announced its entrance into the state of Arizona and raised its full-year 2025 outlook for most financial metrics.

• Total revenue increased by 15.6% to $480.1 million in Q1 2025.
• Net income grew by 41.4% to $4.2 million for the first quarter of 2025.

Grindr reported strong first quarter 2025 results with significant revenue growth of 25% year-over-year, reaching $93.9 million. The company also achieved a net income of $27.0 million and a solid Adjusted EBITDA margin of 43.3%, exceeding prior year performance.

• Revenue increased by 25% to $93.9 million for the first quarter of 2025.
• Net income for the quarter was $27.0 million, a significant improvement from a loss in the prior year.

Playtika Holding Corp. announced a record-breaking first quarter for 2025, with revenue reaching $706.0 million, an 8.6% sequential increase and 8.4% year-over-year increase. The company's DTC platforms revenue also saw significant growth, increasing 2.6% sequentially and 4.5% year-over-year. Despite a decrease in GAAP Net Income and Adjusted EBITDA year-over-year, the company highlighted the continued success of its largest title, Bingo Blitz, and the positive impact of the SuperPlay acquisition.

• Revenue reached a record $706.0 million, increasing 8.6% sequentially and 8.4% year-over-year.
• DTC platforms revenue grew 2.6% sequentially and 4.5% year-over-year, reaching $179.2 million.

Enovis delivered a strong first quarter in 2025 with revenues and margins exceeding expectations, driven by continued commercial momentum and growth in both Prevention & Recovery and Reconstructive segments.

• First-quarter net sales grew 8% on a reported basis and 9% on a comparable basis year-over-year.
• Adjusted EBITDA was $99 million, or 17.7% of sales, a 160 basis point increase from the prior-year quarter.

Yelp exceeded its first quarter expectations, reporting an 8% year-over-year increase in Net Revenue to $359 million. Net Income rose significantly by 72% to $24 million, while Adjusted EBITDA grew 32% to $85 million, reflecting a strong 24% margin.

• Net Revenue increased by 8% year over year to $359 million.
• Net Income increased by 72% year over year to $24 million, reflecting a 7% margin.

Appian demonstrated strong earnings potential in Q1 2025 with narrowing GAAP net losses, the third consecutive quarter of positive adjusted EBITDA, and significant operating cash flow. Total revenue increased 11% year-over-year, driven by a 14% increase in total subscriptions revenue.

• Total revenue for Q1 2025 was $166.4 million, an 11% increase year-over-year.
• Cloud subscriptions revenue grew 15% year-over-year to $99.8 million.

Melco Resorts & Entertainment Limited reported increased total operating revenues and net income for the first quarter of 2025, driven by improved performance in gaming and non-gaming operations. Adjusted Property EBITDA also saw a significant increase. The company highlighted strong performance in Macau and growth in Cyprus, while City of Dreams Manila faced increased competition.

• Total operating revenues increased by approximately 11% to US$1.23 billion in Q1 2025.
• Net income attributable to Melco Resorts & Entertainment Limited rose to US$32.5 million in Q1 2025 from US$15.2 million in Q1 2024.

Spectrum Brands Holdings reported a challenging second quarter for fiscal 2025, with net sales decreasing by 6.0%. The decline was primarily attributed to softening North American demand in Global Pet Care and Home and Personal Care, as well as the timing of seasonal inventory purchases in Home & Garden. Net income from continuing operations significantly decreased by 96.4% to $1.8 million, and Adjusted EBITDA fell by 36.5% to $71.3 million.

• Net sales decreased 6.0% year-over-year, largely due to weaker North American consumer demand and shifts in retailer inventory purchases.
• Net income from continuing operations plummeted by 96.4% to $1.8 million.

Ziff Davis reported a 4.5% increase in total revenues for Q1 2025 compared to the prior year, reaching $328.6 million. Net income saw a significant increase of 128.1% to $24.2 million, while Adjusted EBITDA and Adjusted net income decreased slightly. Free cash flow was negative in Q1 2025, primarily due to working capital usage by TDS Gift Cards.

• Total revenues increased by 4.5% to $328.6 million in Q1 2025.
• Net income increased significantly by 128.1% to $24.2 million.

Alamo Group Inc. reported a decrease in net sales for the first quarter of 2025 compared to the prior year, but showed sequential improvement from the previous quarter. Despite the sales decline, the company improved its operating margin and gross margin, driven by cost reduction efforts. Net income and diluted EPS remained stable year-over-year.

• Net Sales for Q1 2025 were $391.0 million, an 8.1% decrease year-over-year but a 1.5% increase sequentially.
• Operating income was $44.5 million, representing an 11.4% margin, an increase of 40 basis points year-over-year and 130 basis points sequentially.

Ligand Pharmaceuticals reported a significant increase in total revenues and other income for the first quarter of 2025, primarily due to a 44% growth in royalty revenue. Despite the revenue growth, the company reported a GAAP net loss, largely influenced by a one-time charge related to a royalty financing agreement. Ligand reaffirmed its full-year 2025 financial guidance.

• Total revenues and other income for Q1 2025 increased by 46% to $45.3 million, up from $31.0 million in Q1 2024.
• Royalty revenue grew by 44% to $27.5 million in Q1 2025, compared to $19.1 million in Q1 2024, driven by Qarziba and Filspari.

TransMedics delivered strong top and bottom-line financial results in Q1 2025, with total revenue increasing 48% year-over-year to $143.5 million and net income reaching $25.7 million. The company also raised its full-year 2025 revenue guidance.

• Total revenue in Q1 2025 was $143.5 million, a 48% increase compared to Q1 2024.
• Net income for Q1 2025 was $25.7 million, or $0.70 per fully diluted share.

Progyny reported a strong start to 2025 with record first-quarter revenue of $324.0 million, a 16.5% increase year-over-year. The growth was primarily driven by an increase in clients and covered lives. The company also raised its full-year guidance.

• First quarter 2025 revenue reached $324.0 million, a 16.5% increase compared to the same period in 2024.
• Fertility benefit services revenue grew by 22% to $206.4 million.

Sprout Social reported strong results in the first quarter of 2025, with 13% revenue growth, a 21% increase in cRPO, and expanded profitability, driven by focus on enterprise customers and strategic investments.

• Revenue grew by 13% year-over-year to $109.3 million.
• GAAP operating loss improved to ($11.2) million from ($13.3) million in the prior year.

Iovance Biotherapeutics reported total product revenue of $49.3 million for the first quarter of 2025, primarily driven by Amtagvi sales. The company experienced a net loss of $116.2 million, or $0.36 per share. The revenue was impacted by a reduction in capacity due to scheduled maintenance at their manufacturing facility, but full production has resumed.

• Total product revenue for Q1 2025 was $49.3 million, a significant increase from $0.7 million in Q1 2024, primarily due to the U.S. launch of Amtagvi.
• Amtagvi sales contributed $43.6 million, while Proleukin sales accounted for $5.7 million.

Perimeter Solutions reported a significant increase in net income and a strong rise in Adjusted EBITDA for Q1 2025, driven by increased net sales in both Fire Safety and Specialty Products segments. The company also completed an acquisition and repurchased shares during the quarter.

• Net sales increased by 22% to $72.0 million compared to the prior year quarter.
• Net income was $56.7 million, a substantial improvement from a net loss in the prior year.

Wolverine Worldwide reported strong first-quarter 2025 results, with revenue increasing by 4.4% to $412.3 million and diluted EPS reaching $0.13, a significant improvement from a loss in the prior year. The company saw double-digit growth in Merrell and Saucony brands and a record gross margin performance.

• Total revenue for Q1 2025 was $412.3 million, a 4.4% increase year-over-year.
• Diluted Earnings Per Share (EPS) was $0.13, compared to a loss of $0.19 in Q1 2024.

Rocket Companies delivered adjusted revenue at the high end of their guidance range in Q1 2025, demonstrating the strength of their platform. The company also announced significant strategic acquisitions of Redfin and Mr. Cooper Group, aiming to integrate home search, origination, and servicing.

• Generated total revenue, net of $1.0 billion and adjusted revenue of $1.3 billion in Q1 2025.
• Reported a GAAP net loss of $212 million and adjusted net income of $80 million for the quarter.

Vital Farms reported record first quarter net revenue of $162.2 million, a 9.6% increase year-over-year, and reaffirmed its fiscal year 2025 outlook for net revenue and Adjusted EBITDA. The company saw continued volume and net revenue growth, expanded its family farm network, and is on track to meet its 2027 net revenue target of $1 billion.

• Record first quarter net revenue of $162.2 million, up 9.6% from the prior year period.
• Reaffirmed fiscal year 2025 outlook of $740 million in net revenue and $100 million in Adjusted EBITDA.

Hut 8 posted a $134.3M net loss in Q1 2025 as revenue dropped year-over-year. The company completed a major ASIC fleet upgrade and launched a new subsidiary focused on Bitcoin mining.

• Revenue decreased to $21.8M from $51.7M YoY.
• Net loss totaled $134.3M due to losses on digital assets and restructuring costs.

Astrana Health, Inc. reported a strong start to 2025 with total revenue increasing by 53% to $620.4 million. However, net income attributable to Astrana decreased to $6.7 million from $14.8 million in the prior year, and diluted EPS fell to $0.14 from $0.31. Adjusted EBITDA also saw a decrease to $36.4 million from $42.2 million.

• Total revenue increased by 53% to $620.4 million in Q1 2025, up from $404.4 million in Q1 2024.
• Care Partners revenue grew by 57% to $601.0 million, compared to $382.3 million in the same period last year.

NCR Voyix reported first quarter 2025 results that were in line with expectations, despite a softer economic environment. Revenue decreased year-over-year, but net loss improved and Adjusted EBITDA increased. The company maintained its full-year 2025 outlook.

• Total revenue for the first quarter was $617 million, a decrease from $710 million in the prior year period.
• Net loss from continuing operations attributable to NCR Voyix improved to $20 million from a loss of $71 million in the prior year.

10x Genomics reported a 10% increase in total revenue for Q1 2025, driven by a patent litigation settlement. Excluding the settlement, revenue decreased by 2% year-over-year, primarily due to lower instrument sales. The company ended the quarter with $426.9 million in cash and marketable securities and announced cost reduction initiatives.

• Total revenue for Q1 2025 was $154.9 million, a 10% increase year-over-year.
• Excluding a $16.8 million patent litigation settlement, revenue was $138.1 million, a 2% decrease year-over-year.

N-able exceeded its first quarter revenue and Adjusted EBITDA guidance, driven by continued progress in cyber-resiliency and strong partner program growth. The company reported total revenue of $118.2 million and Adjusted EBITDA of $31.6 million.

• Total revenue for Q1 2025 was $118.2 million, a 3.9% year-over-year growth.
• Subscription revenue reached $116.8 million, showing a 4.8% year-over-year increase.

Sphere Entertainment posted Q1 2025 revenue of $280.6M, down 13% year-over-year, with an operating loss of $78.6M and adjusted operating income of $36.0M. Net loss was $82.0M, or $2.27 per share, driven by decreased revenues in both Sphere and MSG Networks segments. Event-related revenues rose significantly due to more concerts and a large corporate event, partially offsetting declines in other areas.

• Total revenue fell 13% to $280.6M, with declines in both Sphere and MSG Networks segments.
• Adjusted operating income dropped 42% to $36.0M.

International Seaways reported a net income of $50 million for the first quarter of 2025, or $1.00 per diluted share, a decrease from $144 million in the first quarter of 2024. Total shipping revenues were $183 million, down from $274 million in the prior year, primarily due to lower TCE revenues from decreased spot rates across its tanker fleet.

• Net income for Q1 2025 was $50 million, or $1.00 per diluted share.
• Adjusted net income for Q1 2025 was $40 million, or $0.80 per diluted share.

Arhaus reported a mixed first quarter for 2025, with net revenue increasing by 5.5% to $311 million, but net income and Adjusted EBITDA saw significant decreases of 67.6% and 36.2% respectively. Comparable growth was negative at (1.5)%, while demand comparable growth was positive at 4.1%. The company opened 1 new showroom and completed 4 strategic relocations during the quarter.

• Net revenue increased 5.5% to $311 million.
• Net and comprehensive income decreased 67.6% to $5 million.

EverCommerce announced robust financial results for the first quarter of 2025, with revenue from continuing operations reaching $142.3 million, a 3.2% increase year-over-year. The company also reported a net income of $0.9 million, a significant improvement from a net loss in the prior year, and Adjusted EBITDA of $44.9 million, surpassing guidance.

• Revenue from continuing operations increased by 3.2% to $142.3 million.
• Net income from continuing operations was $0.9 million, a turnaround from a $16.0 million net loss in the prior year.

Global Partners LP reported solid first-quarter 2025 financial results, with net income of $18.7 million, a significant improvement from a net loss in the prior year. The company saw increased sales and product margins across its Wholesale and Commercial segments, benefiting from favorable market conditions and strategic asset integration.

• Net income for Q1 2025 was $18.7 million, a substantial increase from a net loss of $5.6 million in Q1 2024.
• Total sales reached $4.6 billion in Q1 2025, up from $4.1 billion in Q1 2024.

MannKind Corporation reported strong financial results for the first quarter of 2025, with significant increases in total revenue, net income, and non-GAAP net income compared to the same period in the prior year. The company also made progress on key pipeline programs, including Afrezza for pediatric patients and MNKD-101.

• Total revenues increased by 18% year-over-year to $78.4 million in Q1 2025.
• Net income rose by 24% to $13.2 million in Q1 2025.

Structure Therapeutics Inc. reported a net loss of $46.833 million for the three months ended March 31, 2025, compared to a net loss of $26.036 million for the same period in 2024. This increased loss was primarily due to a significant rise in research and development expenses, which more than doubled year-over-year, and an increase in general and administrative costs. The company's cash and cash equivalents, along with short-term investments, totaled $836.9 million as of March 31, 2025, which management believes is sufficient to fund operations through at least 2027.

• Net loss increased to $46.833 million in Q1 2025 from $26.036 million in Q1 2024, primarily due to higher operating expenses.
• Research and development expenses significantly increased by 107% to $42.867 million, driven by preclinical research, clinical trial costs, and employee expenses.

Himax Technologies, Inc. reported Q1 2025 revenues of $215.1 million, a sequential decrease of 9.3% but a year-over-year increase of 3.7%. Gross margin was 30.5%, and diluted EPS was 11.4 cents, exceeding guidance.

• Q1 2025 revenues were $215.1M, reaching the high end of the guidance range despite a 9.3% QoQ decrease.
• Gross margin for Q1 2025 was 30.5%, in line with guidance and up from 29.3% in the same period last year due to favorable product mix and cost optimization.

Krispy Kreme's first quarter of fiscal year 2025 saw a significant decrease in net revenue and a net loss, largely influenced by the divestiture of Insomnia Cookies. Despite this, the company continued to expand its global points of access and focused on strategic initiatives for profitable growth.

• Net revenue decreased by 15.3% to $375.2 million, primarily due to the Insomnia Cookies divestiture.
• The company reported a GAAP net loss of $33.4 million, a significant increase from the prior year's loss.

NETSCOUT closed fiscal year 2025 on a strong note, with fourth-quarter revenue exceeding expectations, driven by solid performance in its Cybersecurity product line. The company reported total revenue of $205.0 million for Q4 FY25, with GAAP net income of $18.6 million and non-GAAP net income of $38.0 million.

• Fourth-quarter revenue of $205.0 million exceeded expectations, primarily due to strong performance in the Cybersecurity product line.
• Product revenue for Q4 FY25 was $89.5 million, representing approximately 44% of total revenue, consistent with the prior year.

Goldman Sachs BDC, Inc. reported a total investment income of $96.94 million for Q1 2025, a decrease from $111.54 million in Q1 2024. Net income after taxes also saw a decline to $49.61 million from $60.86 million in the prior year. The decrease was mainly attributed to investments being placed on non-accrual status and the restructuring of certain debt investments.

• Total investment income decreased to $96.94 million in Q1 2025 from $111.54 million in Q1 2024.
• Net investment income after taxes declined to $49.61 million in Q1 2025 from $60.86 million in Q1 2024.

Novavax, Inc. reported a net income of $518.6 million on total revenue of $666.7 million for the three months ended March 31, 2025. This represents a substantial increase compared to a net loss of $147.6 million and total revenue of $93.9 million in the same period last year. The significant revenue growth was primarily due to the termination of advance purchase agreements (APAs) with Canada and New Zealand, and initial revenue recognition from the Sanofi Collaboration and License Agreement.

• Total revenue for Q1 2025 increased by $572.8 million to $666.7 million, up from $93.9 million in Q1 2024.
• The company achieved a net income of $518.6 million in Q1 2025, a significant improvement from a net loss of $147.6 million in Q1 2024.

Sapiens delivered a strong start to 2025, with revenue increasing by 1.4% to $136.1 million and diluted EPS reaching $0.32. The company's strategic growth priorities, including new deals and successful acquisitions, contributed to the positive performance.

• Revenue increased by 1.4% to $136.1 million in Q1 2025 compared to Q1 2024.
• Diluted EPS was $0.32 in Q1 2025, up from $0.31 in Q1 2024.

Wave Life Sciences reported a net loss of $46.878 million for the first quarter of 2025, compared to a net loss of $31.558 million in the prior year quarter. Revenue decreased to $9.175 million from $12.538 million in the same period last year. The company ended the quarter with $243.075 million in cash and cash equivalents, with a runway expected into 2027.

• Dosing completed in the first two cohorts of INLIGHT trial for WVE-007 in obesity, with clinical data expected in 2H 2025.
• Dosing underway in RestorAATion-2 clinical trial for WVE-006, with data from complete 200 mg multidose and single dose cohorts expected in 3Q 2025.

Dyne Therapeutics reported a net loss of $115.4 million for the first quarter of 2025. The company is advancing its lead programs, DYNE-101 and DYNE-251, towards potential U.S. Accelerated Approval submissions in 2026, and strengthened its leadership team in preparation for potential regulatory filings and commercial launches.

• FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1.
• Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated.

Altice USA reported a decrease in total revenue and a net loss for the first quarter of 2025, despite achieving record customer growth in fiber and mobile services and reaching three-year lows for customer and broadband churn.

• Total revenue decreased by 4.4% year over year to $2.2 billion.
• Reported a net loss attributable to stockholders of $75.7 million.

BioLife Solutions delivered a strong start to 2025, with total revenue increasing by 30% year-over-year to $23.9 million, primarily driven by a 33% growth in cell processing platform revenue. The company also significantly improved its profitability, reporting a GAAP net loss of $0.4 million and non-GAAP adjusted EBITDA of $5.7 million, or 24% of revenue.

• Cell Processing revenue increased by 33% over Q1 2024, reaching $21.6 million.
• Non-GAAP adjusted EBITDA grew to $5.7 million, representing 24% of revenue, up from 14% in Q1 2024.

Liquidia reported a net loss of $38.4 million for the first quarter of 2025, an increase from the $30.1 million net loss in the same period last year. Revenue remained relatively stable at $3.1 million, primarily from their promotion agreement for Treprostinil Injection. The company's cash and cash equivalents decreased slightly to $169.8 million.

• Net loss increased to $38.4 million in Q1 2025 compared to $30.1 million in Q1 2024.
• Revenue was $3.1 million in Q1 2025, a slight increase from $3.0 million in Q1 2024, primarily from the Treprostinil Injection promotion agreement.

Papa John’s saw modest revenue growth driven by higher commissary and advertising fund contributions, but profits declined as the company invested in marketing, loyalty programs, and hosted a franchisee conference.

• Total revenue increased slightly to $518.3 million, up from $513.9 million in Q1 2024.
• Net income dropped to $9.3 million, down from $14.9 million year-over-year.

HCI Group, Inc. announced a strong first quarter for 2025, with pre-tax income reaching $100.3 million and net income of $74.2 million. Diluted earnings per share increased to $5.35 from $3.81 in the prior year. The company also announced plans for a potential tax-free spin-off of Exzeo by the end of the year.

• Diluted EPS increased to $5.35 in Q1 2025, up from $3.81 in Q1 2024.
• Pre-tax income reached $100.3 million in Q1 2025, a significant increase from the previous year.

Aimco reported a net loss attributable to common stockholders of $(0.10) per share for the first quarter of 2025. Stabilized Operating Properties saw a 2.7% increase in Net Operating Income year-over-year, driven by higher average monthly revenue per apartment home and stable occupancy. The company is focused on its development pipeline and the planned sale of the Brickell Assemblage for $520 million to $540 million, with proceeds largely intended for distribution to stockholders.

• Net loss attributable to common stockholders per share was $(0.10) for Q1 2025.
• Stabilized Operating Properties NOI increased 2.7% year-over-year to $25.1 million.

Fox Factory Holding Corp. reported net sales of $355.0 million for the first quarter of fiscal 2025, a 6.5% increase year-over-year. The company experienced a net loss of $259.7 million, primarily due to a significant goodwill impairment charge, while adjusted net income was $9.8 million.

• Net sales for Q1 fiscal 2025 were $355.0 million, up 6.5% from the prior year.
• The company reported a net loss of $259.7 million in Q1 fiscal 2025, heavily impacted by a $262.3 million goodwill impairment.

Blue Bird Corporation achieved record quarterly revenue and profit in Q2 2025, driven by strong market demand, product mix, and pricing. The company reaffirmed its full-year Adjusted EBITDA guidance of $200 million.

• Achieved record quarterly revenue of $358.9 million.
• Reported GAAP Net Income of $26.0 million.

ScanSource, Inc. announced its third quarter fiscal year 2025 results, with net sales of $704.8 million, a 6.3% decrease year-over-year. Despite the decline in sales, the company saw significant improvements in profitability, with gross profit increasing by 6.1% to $100.2 million and GAAP net income rising by 36.1% to $17.4 million. Diluted EPS increased by 48.0% to $0.74.

• Net sales for Q3 FY25 were $704.8 million, a 6.3% decrease from Q3 FY24.
• Gross profit increased by 6.1% to $100.2 million, with gross profit margin expanding to 14.2% from 12.6% in the prior year.

Olo reported a strong start to fiscal year 2025 with total revenue increasing 21% year-over-year to $80.7 million and non-GAAP operating income reaching $11.5 million, exceeding the high end of their guidance. The company saw an increase of approximately 2,000 active locations and a 12% increase in ARPU.

• Total revenue for Q1 2025 was $80.7 million, a 21% increase year-over-year.
• Non-GAAP operating income was $11.5 million, exceeding the guidance range.

Janus International Group reported a decrease in revenues and net income for the first quarter of 2025 compared to the prior year. Revenues were $210.5 million, down 17.3%, and net income was $10.8 million, a 64.8% decrease. Adjusted EBITDA also saw a significant decline.

• Total revenues decreased by 17.3% to $210.5 million in Q1 2025 from $254.5 million in Q1 2024.
• Net income fell by 64.8% to $10.8 million, resulting in diluted EPS of $0.08.

Pacira BioSciences reported total revenues of $168.9 million for the first quarter of 2025, a slight increase from the prior year. Net income was $4.8 million, or $0.10 per share, compared to $9.0 million, or $0.19 per share, in the first quarter of 2024. Adjusted EBITDA was $44.1 million.

• Total revenues increased slightly to $168.9 million in Q1 2025 from $167.1 million in Q1 2024.
• GAAP net income decreased to $4.8 million ($0.10 per share) in Q1 2025 from $9.0 million ($0.19 per share) in Q1 2024.

Chimera Investment Corporation reported a strong first quarter in 2025, with earnings available for distribution improving by 11%, book value increasing by 7.4%, and an economic return of 9.2%. The company also successfully completed a cash-out refinancing of non-Remic securitizations, providing $187 million for new investments, and extended two large non-mark-to-market secured financing facilities until 2027.

• GAAP Net Income per Diluted Common Share was $1.77 for Q1 2025.
• Earnings Available for Distribution per Diluted Common Share was $0.41 for Q1 2025.

Applied Optoelectronics delivered results in line with or better than expectations, driven by strong demand in the CATV market, achieving the highest quarterly CATV revenue in company history. The company also saw increased engagement and design wins in the datacenter business and is actively building capacity for 400G and 800G products.

• Achieved highest quarterly CATV revenue in company history.
• Secured three new design wins with an existing hyperscale customer for datacenter products.

Arlo delivered strong results in Q1 2025, driven by significant growth in subscriptions and services revenue, leading to record non-GAAP EPS and free cash flow.

• Record subscriptions and services revenue of $68.8 million, up 21.4% year over year.
• Annual Recurring Revenue (ARR) reached $276.4 million, a 21.8% increase year over year.

Cars.com reported first-quarter revenue of $179.0 million, a slight decrease from the prior year. The company experienced a net loss of $2.0 million, or ($0.03) per diluted share, compared to net income in the prior year. Despite this, Cars.com achieved a new record of 29.0 million average monthly unique visitors and saw an increase in dealer customers to 19,250, reflecting strong solutions adoption.

• Total revenue for Q1 2025 was $179.0 million, a 1% decrease year-over-year.
• Net loss for Q1 2025 was $2.0 million, compared to net income of $0.8 million in Q1 2024.

Evolent Health, Inc. reported strong first quarter 2025 results, meeting the high end of their expectations for revenue and reaffirming their full-year 2025 outlook. The company saw significant organic growth with five new revenue agreements and continued to scale its oncology condition management solution, improving member experience and cost outcomes.

• Revenue for Q1 2025 was $483.6 million, aligning with the high end of expectations.
• Adjusted EBITDA for Q1 2025 was $36.86 million, with an Adjusted EBITDA Margin of 7.6%.

Ready Capital Corporation reported GAAP earnings per common share from continuing operations of $0.47 and a distributable loss per common share of $(0.09) for the first quarter of 2025. The company's net income was $81.965 million, with total assets of $9.976 billion. Despite market volatility and declining consumer confidence, the company focused on resetting its balance sheet and restoring profitability.

• GAAP Earnings Per Common Share from Continuing Operations was $0.47.
• Distributable Loss Per Common Share was $(0.09).

Owens & Minor reported a slight increase in revenue to $2.632 billion for Q1 2025, up from $2.613 billion in Q1 2024. The company experienced a net loss of $24.982 million, or $0.32 per common share, but reported adjusted net income of $18.073 million, or $0.23 per share. The Patient Direct segment showed strong performance with mid-single digit top-line growth and mid-teen expansion in EBITDA.

• Revenue for Q1 2025 was $2.632 billion, a slight increase from the previous year.
• Patient Direct segment led top-line growth and expanded its operating margin by 173 basis points.

Dave reported strong financial results for the first quarter of 2025, with revenue increasing 47% year-over-year to $108.0 million. GAAP Net Income reached $28.8 million, and Adjusted EBITDA significantly increased by 235% year-over-year to $44.2 million. The company also raised its full-year 2025 guidance for both revenue and Adjusted EBITDA.

• Q1 2025 GAAP Operating Revenues, Net increased 47% year-over-year to $108.0 million.
• Q1 2025 GAAP Net Income was $28.8 million.

Liquidity Services announced a significant increase in Gross Merchandise Volume (GMV) by 15% to $367.4 million and revenue by 27% to $116.4 million for Q2 FY25, compared to the prior year. GAAP Net Income rose 24% to $7.1 million, with diluted EPS at $0.22, while Non-GAAP Adjusted EBITDA increased 1% to $12.2 million and Non-GAAP Adjusted EPS grew 15% to $0.31. The company maintained strong cash balances of $149.0 million with no financial debt.

• Gross Merchandise Volume (GMV) increased by 15% to $367.4 million, reflecting strong growth across segments.
• Total revenue grew by 27% to $116.4 million, with significant contributions from RSCG and Machinio & Software Solutions.

Collegium Pharmaceutical delivered a strong first quarter in 2025, with significant revenue growth driven by both their ADHD and Pain portfolios. The company grew revenue by 23% year-over-year, made strategic investments in Jornay PM, and generated robust operating cash flows, increasing their cash position while also reducing debt.

• Generated Q1'25 Quarterly Net Revenue of $177.8 Million, Up 23% Year-over-Year.
• Grew Jornay PM Prescriptions by 24% Year-over-Year and Reported Quarterly Net Revenue of $28.5 Million.

ACM Research reported a 13.2% year-over-year revenue increase in Q1 2025, driven by higher sales in wafer cleaning and front-end processing. The company maintained solid operating margins and generated positive cash flow despite a temporary drop in shipments due to earlier pull-ins.

• Revenue grew 13.2% YoY to $172.3 million.
• Non-GAAP EPS was $0.46, reflecting a strong operating margin of 20.7%.

Pursuit Attractions and Hospitality, Inc. delivered solid performance in the first quarter of 2025, with revenue increasing by 0.9% to $37.6 million and diluted EPS improving to -$1.11 from -$1.29 in the prior year. The company maintained its outlook for strong full-year 2025 growth, driven by increased effective ticket prices and lodging RevPAR.

• Revenue increased by 0.9% year-over-year to $37.6 million, primarily due to growth in ticket revenue at year-round attractions and higher effective ticket prices.
• Net loss attributable to Pursuit was $31.1 million, a 24.0% increase from the prior year, mainly due to the discontinued operations treatment of GES results in 2024.

Intellia Therapeutics reported a net loss of $114.3 million for the first quarter of 2025, compared to a net loss of $107.4 million in the same period last year. Collaboration revenue decreased to $16.6 million from $28.9 million, primarily due to a decrease in the AvenCell license and collaboration agreement. The company ended the quarter with $707.1 million in cash, cash equivalents, and marketable securities, and expects to fund operations into the first half of 2027.

• Intellia is on track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025.
• The first patient was dosed in the global Phase 3 MAGNITUDE-2 study for hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN).

Olaplex reported a solid start to the year with first quarter net sales of $97.0 million, slightly ahead of expectations despite a 1.9% decrease year-over-year. Net income significantly decreased to $0.5 million compared to $7.7 million in the prior year, resulting in diluted EPS of $0.00. The company reiterated its full-year fiscal 2025 guidance.

• Net sales for the first quarter of 2025 decreased 1.9% to $97.0 million.
• Net income for the first quarter was $0.5 million, a significant decrease from $7.7 million in the prior year.

AMN Healthcare reported first quarter 2025 revenue of $690 million, a 16% decrease year-over-year. The company posted a GAAP net loss of $1.1 million and adjusted diluted EPS of $0.45. Results were above the high end of guidance, benefiting from growth in client patient volumes and market adoption of tech-enabled solutions.

• First quarter revenue and earnings exceeded guidance expectations.
• Consolidated gross margin was better than guidance, and SG&A management improved operating leverage.

Pulse Biosciences reported a net loss of $16.795 million for Q1 2025, an increase from $10.137 million in Q1 2024. Total costs and expenses increased significantly, driven by non-cash stock-based compensation and administrative expenses. The company is advancing its nsPFA technology with several clinical trials and commercialization efforts.

• Total GAAP costs and expenses for Q1 2025 were $18.0 million, up from $10.6 million in the prior year period.
• GAAP net loss for Q1 2025 was $16.795 million, compared to $10.137 million in Q1 2024.

The RealReal delivered a strong first quarter in 2025, exceeding expectations with an 11% increase in total revenue and a substantial improvement in net income, driven partly by non-cash gains. The company also saw a significant positive shift in Adjusted EBITDA and reaffirmed its full-year guidance, indicating confidence in its strategic execution and ability to navigate market uncertainties.

• Q1 2025 revenue was $160 million, an 11% increase compared to Q1 2024.
• Net income for Q1 2025 was $62 million, a significant improvement from a loss of $31 million in Q1 2024.

PDF Solutions, Inc. announced its first quarter 2025 financial results with total revenues of $47.8 million, a 16% increase year-over-year. The company reported a GAAP net loss of $3.0 million, or ($0.08) per diluted share, but a non-GAAP net income of $8.1 million, or $0.21 per diluted share. The quarter also saw the acquisition of SecureWise LLC.

• Total revenues for Q1 2025 were $47.8 million, marking a 16% increase compared to the same quarter last year.
• Analytics revenue reached $42.5 million, up 10% year-over-year.

AbCellera reported a total revenue of $4.2 million for Q1 2025, a decrease from $10.0 million in Q1 2024. The company experienced a net loss of $45.6 million, compared to a net loss of $40.6 million in the prior year. Despite the loss, AbCellera maintained strong liquidity with over $800 million in available funds and is advancing new antibody programs into clinical trials.

• Total revenue for Q1 2025 was $4.2 million, primarily from research fees.
• Net loss for Q1 2025 was $45.6 million, or $(0.15) per share.

Blend Labs, Inc. reported strong first quarter 2025 financial results, with total revenue of $26.77 million, exceeding consensus estimates. The company achieved positive free cash flow for the first time in its history, driven by increased cash provided by operating activities. Key drivers included significant customer growth, accelerated adoption of Rapid Home Lending solutions, and strategic partnerships with leading mortgage servicers. The company also initiated a process to sell its Title365 business to focus on its software-first model.

• Blend Platform revenue reached $26.8 million, surpassing consensus estimates and guidance midpoint.
• The company achieved record first quarter signings, with total remaining performance obligations increasing by 70% year-over-year to $158.1 million.

Innodata reported a strong start to 2025, with revenue increasing by 120% year-over-year to $58.3 million. Adjusted EBITDA saw a substantial increase to $12.7 million, up from $3.8 million in the same period last year. The company also reported a net income of $7.8 million, or $0.25 per basic share.

• Revenue grew by 120% year-over-year, reaching $58.3 million in Q1 2025.
• Adjusted EBITDA increased significantly to $12.7 million from $3.8 million in the prior year's quarter.

Natural Grocers by Vitamin Cottage, Inc. announced robust financial results for the three months ended March 31, 2025, demonstrating substantial growth across key metrics. Net sales increased by 9.0% to $335.8 million, driven by strong comparable store sales and new store contributions. Net income saw a remarkable 64.6% increase, reaching $13.1 million, while diluted EPS rose to $0.56. The company's gross profit also improved, reflecting effective promotions.

• Net sales increased by 9.0% to $335.8 million for the three months ended March 31, 2025, compared to $308.1 million in the prior year.
• Net income surged by 64.6% to $13.1 million for the quarter, up from $8.0 million in the same period last year.

Wolfspeed's consolidated revenue for Q3 FY2025 was $185.4 million, a decrease from $200.7 million in the prior year. The company reported a GAAP net loss of $285.5 million and a GAAP loss per share of ($1.86). Despite the financial losses, Wolfspeed highlighted progress in strengthening its capital structure and strategic initiatives, including a significant increase in Mohawk Valley Fab revenue.

• Consolidated revenue for the quarter decreased to $185 million, compared to $201 million in the same period last year.
• The company reported a GAAP gross margin of (12)% and a GAAP loss per share of ($1.86).

Harrow reported a 38% increase in first-quarter 2025 revenue to $47.8 million compared to the prior year, driven by strong performance in key products like VEVYE. Despite a GAAP net loss of $17.8 million and negative Adjusted EBITDA of $2.0 million, the company achieved a record high cash flow from operations of $19.7 million and ended the quarter with $66.7 million in cash.

• Total revenues increased by 38% year-over-year to $47.8 million.
• VEVYE revenues grew by 35% quarter-over-quarter to $21.5 million.

Golden Entertainment reported first quarter 2025 revenues of $160.8 million, a decrease from $174.0 million in Q1 2024. Net income for the quarter was $2.5 million, or $0.09 per fully diluted share, significantly lower than $42.0 million in Q1 2024, which included a large gain from a business sale. The company repurchased 273,945 shares of common stock for $7.6 million and maintained $50.5 million in cash and cash equivalents.

• Revenues for Q1 2025 were $160.8 million, down from $174.0 million in Q1 2024.
• Net income for Q1 2025 was $2.5 million ($0.09 per diluted share), a significant decrease from $42.0 million ($1.37 per diluted share) in Q1 2024, primarily due to a one-time gain on sale of distributed gaming operations in 2024.

Aspen Aerogels reported a significant net loss in Q1 2025, primarily due to a large impairment charge related to a planned manufacturing plant. Revenue decreased year-over-year, while adjusted EBITDA also saw a decline. The company highlighted a new PyroThin award and positive operating cash flow.

• Total revenue for Q1 2025 was $78.7 million, a 17% decrease year-over-year.
• Net loss was $301.2 million, heavily impacted by a $286.6 million impairment charge.

Prothena reported a net loss of $60.2 million for the first quarter of 2025, an improvement from the $72.2 million net loss in the first quarter of 2024. Total revenue significantly increased to $2.8 million, primarily due to collaboration revenue from Bristol Myers Squibb. The company ended the quarter with $418.8 million in cash, cash equivalents, and restricted cash.

• Net loss for Q1 2025 was $60.2 million, an improvement from $72.2 million in Q1 2024.
• Total revenue for Q1 2025 was $2.8 million, up from $0.1 million in Q1 2024, primarily from collaboration revenue.

FTAI Infrastructure Inc. reported a net income attributable to stockholders of $109.7 million and diluted earnings per share of $0.89 for the first quarter of 2025. The company also reported Adjusted EBITDA of $155.2 million.

• Net income attributable to stockholders was $109.7 million for Q1 2025.
• Diluted earnings per share was $0.89 for Q1 2025.

Axogen, Inc. reported strong revenue growth in the first quarter of 2025, increasing by 17.4% year-over-year. Despite a decrease in gross margin due to increased product costs and inventory write-offs, the company saw improvements in both GAAP and non-GAAP net loss and adjusted EBITDA compared to the prior year. The company also made significant progress towards the anticipated BLA approval for Avance Nerve Graft.

• First quarter 2025 revenue increased by 17.4% to $48.6 million compared to the first quarter of 2024.
• Gross margin for the first quarter was 71.9%, down from 78.8% in the prior year.

Malibu Boats, Inc. reported a strong third quarter for fiscal year 2025, with significant increases in net sales, gross profit, GAAP net income, and Adjusted EBITDA compared to the same period last year, despite ongoing market challenges and softness in retail demand. The company saw increased unit volumes in the Malibu segment and favorable model mix across all segments, partially offset by decreased unit volumes in the Cobalt and Saltwater Fishing segments.

• Net sales increased 12.4% to $228.7 million compared to the third quarter of fiscal 2024.
• GAAP net income increased 119.4% to $13.2 million, and GAAP diluted EPS increased 120.1% to $0.66 per share.

Zymeworks reported a significant increase in revenue to $27.1 million for Q1 2025, up from $10.0 million in Q1 2024, primarily due to milestone payments from GSK and Daiichi Sankyo. The company also reduced its net loss to $22.6 million from $31.7 million in the prior year. Cash resources stood at $321.6 million, providing a projected cash runway into the second half of 2027.

• Revenue increased to $27.1 million in Q1 2025, up from $10.0 million in Q1 2024.
• Net loss decreased to $22.6 million in Q1 2025, compared to $31.7 million in Q1 2024.

Stagwell Inc. announced its first quarter 2025 financial results, reporting a total revenue of $651.7 million, a 3% decrease from the prior year. Despite the decline in total revenue, net revenue increased by 6% year-over-year, reaching $564.2 million. The company posted a net loss attributable to common shareholders of $3 million and adjusted EBITDA of $81 million. Net new business for the quarter was $130 million.

• Q1 total revenue decreased by 3% year-over-year to $651.7 million.
• Net revenue increased by 6% year-over-year to $564.2 million, with net revenue excluding advocacy growing by 9%.

Cytek Biosciences reported a decrease in total revenue for the first quarter of 2025 compared to the same period last year, primarily due to a slowdown in product sales in the US and EMEA. Despite this, the company saw strength in the APAC region and double-digit revenue growth in cell sorters and service businesses. Net loss increased compared to the prior year.

• Total revenue for Q1 2025 was $41.5 million, a 7.6% decrease year-over-year.
• Gross profit for Q1 2025 was $20.2 million, a 12% decrease year-over-year.

PubMatic exceeded its guidance for revenue and adjusted EBITDA in the first quarter of 2025. The company's underlying business grew 21% year-over-year, driven by strong performance in omnichannel video, including CTV. Supply Path Optimization activity also reached a record high.

• Revenue for Q1 2025 was $63.8 million, slightly down from $66.7 million in Q1 2024.
• GAAP net loss was $(9.5) million, or $(0.20) per diluted share.

Clean Energy reported revenue of $103.8 million in Q1 2025, a slight increase from the prior year. The company posted a significant net loss of $(135.0) million, primarily due to non-cash charges including a goodwill write-down and accelerated depreciation. Adjusted EBITDA showed improvement, reaching $17.1 million.

• Revenue remained relatively flat year-over-year at $103.8 million for Q1 2025.
• Net loss significantly widened to $(135.0) million in Q1 2025, driven by non-cash impairment and depreciation charges.

Xeris Biopharma reported a strong start to 2025 with record first-quarter revenue of over $60 million, a 48% year-over-year increase, driven by significant growth in Recorlev revenue. The company also tightened its full-year total revenue guidance.

• Total revenue increased 48% year-over-year to $60.1 million.
• Recorlev revenue grew 141% year-over-year to $25.5 million, driven by a 124% increase in average number of patients.

ZipRecruiter reported Q1 2025 revenue of $110.1 million, which exceeded the midpoint of their guidance but was down 10% year-over-year. They experienced a net loss of $12.8 million and reported Adjusted EBITDA of $5.9 million.

• Quarterly revenue reached $110.1 million, exceeding guidance midpoint.
• Revenue was down 10% year-over-year and 1% sequentially.

Stratasys reported first-quarter 2025 financial results with revenue of $136.0 million, a GAAP net loss of $13.1 million, and a non-GAAP net income of $2.9 million. The company also reported $8.2 million in Adjusted EBITDA and $4.5 million in cash provided by operating activities. Subsequent to the quarter end, Stratasys added $120 million in cash from an investment by Fortissimo Capital, strengthening its balance sheet and raising its 2025 annual earnings forecast.

• Revenue for Q1 2025 was $136.0 million, a decrease from $144.1 million in the prior year period.
• The company achieved a GAAP net loss of $13.1 million, or $0.18 per diluted share, but a non-GAAP net income of $2.9 million, or $0.04 per diluted share.

Westrock Coffee Company reported solid financial results for the first quarter of 2025, with net sales increasing by 11.1% to $213.8 million. Despite a decrease in gross profit and an increased net loss, the company made significant progress in scaling up its Conway Facility and reaffirmed its 2025 and 2026 guidance for Consolidated Adjusted EBITDA and Segment Adjusted EBITDA.

• Net sales increased by 11.1% to $213.8 million in Q1 2025.
• Consolidated Adjusted EBITDA was $8.2 million, including $3.3 million in scale-up costs for the Conway Facility.

Metallus reported a significant increase in net sales and a return to profitability in Q1 2025 compared to the previous quarter, driven by higher shipments and increased raw material surcharge revenue. However, results were down year-over-year due to unfavorable product mix, lower base sales prices, and lower raw material surcharge revenue per ton.

• Net sales increased 17% sequentially to $280.5 million, but decreased 13% year-over-year.
• Achieved net income of $1.3 million and adjusted EBITDA of $17.7 million in Q1 2025.

Granite Ridge Resources, Inc. delivered strong first-quarter results, exceeding internal forecasts with a 23% year-over-year daily production growth and generating $91.4 million in Adjusted EBITDAX. The company maintained low leverage and increased its borrowing base, positioning itself for continued growth and capital deployment.

• Daily production grew 23% year-over-year to 29,245 Boe per day, with oil comprising 50% of the total.
• Adjusted EBITDAX reached $91.4 million, surpassing internal forecasts.

Green Plains reported a wider net loss in Q1 2025 compared to the same period last year, driven by lower margins in the ethanol production and agribusiness and energy services segments, as well as significant restructuring costs. Despite the loss, the company is focused on cost reduction initiatives and expects positive EBITDA for the remainder of the year based on current market conditions.

• Net loss attributable to Green Plains widened to $72.9 million in Q1 2025 from $51.4 million in Q1 2024.
• Revenues increased slightly to $601.5 million in Q1 2025 from $597.2 million in Q1 2024.

Treace Medical Concepts reported solid growth in the first quarter of 2025 with a 3% increase in revenue to $52.6 million and significant improvements in adjusted EBITDA and net loss compared to the same period in the previous year. The company also expanded its bunion technology portfolio with new product launches and continued to build clinical evidence.

• Generated revenue of $52.6 million in the first quarter 2025, representing growth of 3% over the same period in 2024.
• Improved first quarter 2025 net loss by 15% to $(15.9) million compared to $(18.7) million in the same period in 2024.

Cantaloupe, Inc. announced robust financial results for the third quarter of fiscal year 2025, with total revenue increasing by 11.1% year-over-year to $75.4 million. Net income applicable to common shares surged to $48.9 million, primarily due to a one-time release of a valuation allowance on deferred tax assets. Adjusted EBITDA also saw a substantial increase of 36.6% to $13.9 million, reflecting improved operating leverage and margin expansion.

• Total revenue increased 11.1% year-over-year to $75.4 million.
• Net income applicable to common shares was $48.9 million, or $0.65 diluted earnings per share, significantly up from $4.4 million in the prior year, largely due to a one-time tax benefit.

i3 Verticals, Inc. reported a strong second quarter for fiscal year 2025, with revenue increasing by 8.8% to $63.1 million and a significant turnaround in net income from continuing operations, moving from a net loss of $2.3 million in the prior year to a net income of $1.1 million. The company also completed the acquisition of a utility billing software company and divested its Healthcare RCM Business.

• Second quarter revenue increased by 8.8% year-over-year to $63.1 million.
• Net income from continuing operations shifted from a $2.3 million loss to a $1.1 million income.

Willdan Group exceeded analyst expectations in the first quarter of 2025, delivering double-digit growth across key metrics, driven by new wins, steady funding in core programs, and three strategic acquisitions. The company is raising its fiscal year 2025 financial targets.

• Contract revenue increased by 24.4% to $152.4 million.
• Net income grew by 59.3% to $4.7 million.

Karat Packaging Inc. announced strong first quarter 2025 financial results, with net sales increasing 8.4% to $103.6 million and gross profit up 8.4% to $40.8 million. Net income rose 5.2% to $6.8 million, while adjusted EBITDA decreased to $11.9 million. The company is strategically reducing reliance on China for sourcing and implementing price increases to offset higher costs.

• Net sales increased 8.4% to $103.6 million, driven by a 10.9% increase in sales volume.
• Gross profit grew 8.4% to $40.8 million, maintaining a consistent gross margin of 39.3%.

Varex Imaging Corporation reported strong demand in Q2 FY25, leading to year-over-year sales growth in both segments. The company achieved margin expansion, profitability, and cash generation, with revenues reaching $213 million and non-GAAP EPS increasing to $0.26.

• Revenues increased by 3% year-over-year to $213 million.
• Non-GAAP gross margin improved to 36% from 33% in the prior year.

nLIGHT, Inc. announced a strong start to 2025, with first-quarter revenues of $51.7 million, surpassing guidance due to record results in aerospace and defense. The company also saw significant improvements in gross margin and a reduced net loss compared to the previous year.

• Revenues for Q1 2025 increased by 16.0% to $51.7 million, exceeding the high-end of guidance.
• Gross margin improved significantly to 26.7% in Q1 2025, up from 16.8% in Q1 2024.

Rackspace Technology reported a revenue of $665.4 million for the first quarter of 2025, a decrease of 3.7% year-over-year. The company achieved a net loss of $(71.5) million and an EPS of $(0.31). Non-GAAP operating profit increased by 83% year-over-year to $25.6 million, indicating strong operational momentum.

• Revenue for Q1 2025 was $665.4 million, a 3.7% decrease year-over-year, but at the high end of guidance.
• Non-GAAP Operating Profit increased by 83% year-over-year to $25.6 million, reflecting improved efficiency.

Definitive Healthcare reported Q1 2025 financial results with revenue exceeding guidance, despite a 7% decrease year-over-year. The company posted a significant net loss due to goodwill impairment charges but achieved positive unlevered free cash flow.

• Revenue for Q1 2025 was $59.2 million, a 7% decrease compared to Q1 2024.
• Net loss for Q1 2025 was $(155.1) million, including $176.5 million in goodwill impairment charges.

Clearfield reported net sales of $47.2 million for the second quarter of fiscal 2025, a 28% increase year-over-year, driven by strong demand in the Clearfield segment. The company returned to profitability with net income of $1.3 million, or $0.09 per diluted share, compared to a net loss in the prior year quarter. Gross profit significantly improved to $14.2 million.

• Net sales increased 28% year-over-year to $47.2 million in Q2 Fiscal 2025.
• The company returned to profitability, reporting net income of $1.3 million and diluted EPS of $0.09.

Eastman Kodak Company experienced a slight decrease in total revenues in Q1 2025 compared to Q1 2024, primarily due to lower Print segment volumes and unfavorable foreign currency fluctuations, partially offset by improvements in Advanced Materials and Chemicals. The company reported a net loss for the quarter, a significant decline from net earnings in the prior year period.

• Total revenues decreased by $2 million (1%) to $247 million in Q1 2025 compared to $249 million in Q1 2024.
• The Print segment revenues declined by $17 million (9%) to $165 million, while Advanced Materials and Chemicals revenues increased by $15 million (25%) to $74 million.

Ouster announced strong operating results for the first quarter of 2025, with revenue reaching $33 million, a 26% increase year-over-year. The company significantly improved its GAAP gross margin to 41% and Non-GAAP gross margin to 46%, while reducing its net loss to $22 million and Adjusted EBITDA loss to $8 million.

• Achieved $33 million in revenue in Q1 2025, representing 26% year-over-year growth.
• Reported a GAAP gross margin of 41% and a Non-GAAP gross margin of 46% for the quarter.

Sana Biotechnology reported a net loss of $49.4 million for the first quarter of 2025, a significant improvement compared to the $107.5 million loss in the same period last year. The company ended the quarter with $104.7 million in cash, cash equivalents, and marketable securities, with an expected cash runway into 2026. Sana highlighted positive clinical data for its type 1 diabetes program and progress in its allogeneic CAR T and in vivo CAR T pipelines.

• Net loss for Q1 2025 was $49.4 million, a substantial decrease from $107.5 million in Q1 2024.
• Ended Q1 2025 with $104.7 million in cash, cash equivalents, and marketable securities.

BigCommerce reported a 3% increase in total revenue to $82.4 million for the first quarter of 2025, compared to the prior year. Total ARR also grew by 3% to $350.8 million, with Enterprise ARR increasing by 6% to $263.8 million. The company's GAAP net loss improved significantly to ($0.4) million from ($6.4) million in the same period of the prior year, while Non-GAAP net income was $5.7 million.

• Total revenue reached $82.4 million, a 3% increase year-over-year.
• Total ARR grew by 3% to $350.8 million, and Enterprise ARR increased by 6% to $263.8 million.

Akebia Therapeutics reported a net income of $6.1 million for Q1 2025, a significant improvement from a net loss of $18.0 million in Q1 2024, primarily due to total revenues increasing to $57.3 million, driven by the successful U.S. launch of Vafseo® and strong Auryxia® sales.

• Vafseo® (vadadustat) U.S. product launch generated $12.0 million in net product revenues in Q1 2025.
• Total Q1 2025 net product revenues reached $55.8 million, contributing to overall revenue growth.

DocGo reported a significant decrease in revenue and a net loss in the first quarter of 2025, primarily due to the planned wind-down of migrant-related programs. The company updated its full-year 2025 guidance downward, removing non-migrant municipal population health revenue, while highlighting growth in its Medical Transportation and Payer & Provider businesses.

• Revenue significantly decreased year-over-year due to migrant program wind-down.
• Company shifted focus and guidance to Medical Transportation and Payer & Provider segments.

Green Dot reported a strong start to 2025, exceeding projections with significant growth in total operating revenues and net income compared to the previous year. The company saw continued momentum in embedded finance through new partnerships and a key retail partnership renewal.

• Total operating revenues increased 24% year-over-year to $558.9 million.
• Net income saw a significant increase of 443% year-over-year, reaching $25.8 million.

Theravance Biopharma reported a total revenue of $15.4 million for Q1 2025, primarily from Viatris collaboration revenue. The company saw solid growth in YUPELRI net sales and continued progress in the CYPRESS study for ampreloxetine, with enrollment nearing completion.

• YUPELRI® (revefenacin) net sales, recognized by Viatris, increased 6% to $58.3 million in Q1 2025 compared to Q1 2024.
• TRELEGY net sales, as reported by GSK, increased 14% to $854 million in Q1 2025 compared to Q1 2024.

Organogenesis Holdings Inc. reported a net revenue of $86.7 million for the first quarter of 2025, a 21% decrease from $110.0 million in the prior year. The company experienced a net loss of $18.8 million, a significant increase from a net loss of $2.1 million in the first quarter of 2024. This decline was primarily driven by a 23% decrease in Advanced Wound Care product revenue.

• Net revenue for Q1 2025 was $86.7 million, a 21% decrease from $110.0 million in Q1 2024.
• Net loss for Q1 2025 was $18.8 million, an increase of $16.7 million from a net loss of $2.1 million in Q1 2024.

PacBio reported a decrease in total revenue compared to the prior year, primarily driven by lower instrument revenue. However, consumable revenue and service and other revenue saw increases. GAAP net loss significantly widened due to substantial restructuring charges, while non-GAAP net loss slightly improved. The company initiated a restructuring plan to reduce operating expenses and focus on its long-read business.

• Total revenue decreased to $37.2 million in Q1 2025 from $38.8 million in Q1 2024.
• GAAP net loss was $426.1 million in Q1 2025, compared to $78.2 million in Q1 2024, largely due to restructuring costs.

Mitek Systems reported record revenue and profitability in the second quarter of fiscal 2025, with strong SaaS revenue growth. The company also secured a term loan facility to retire its 2026 Convertible Notes and raised its adjusted EBITDA margin guidance for fiscal 2025.

• Achieved all-time record revenue of $51.9 million in Q2 fiscal 2025.
• Reported record profitability with GAAP net income of $9.2 million and Non-GAAP net income of $16.7 million.

Vaalco Energy, Inc. delivered a successful first quarter in 2025, meeting or exceeding guidance with solid net income and Adjusted EBITDAX, driven by strong NRI production and sales. The company also made strategic advancements, including securing a new credit facility and progressing organic growth projects in Côte D'Ivoire and Gabon, while reducing full-year capital expenditure guidance.

• Net income for Q1 2025 was $7.7 million ($0.07 per diluted share), with Adjusted Net Income of $6.3 million ($0.06 per diluted share).
• Adjusted EBITDAX totaled $57.0 million in Q1 2025, a 25% decrease from Q4 2024 but a strong performance.

Autolus Therapeutics reported Q1 2025 net product revenue of $9.0 million for AUCATZYL, driven by strong physician enthusiasm and increasing patient access. The company also secured conditional marketing authorization for AUCATZYL in the UK and reported encouraging preliminary data from the Phase 1 CARLYSLE trial for systemic lupus erythematosus, with plans to advance into pivotal Phase 2 trials.

• Q1 2025 AUCATZYL® net product revenue reached $9.0 million.
• Conditional marketing authorization for AUCATZYL® was granted by the U.K. MHRA for relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL).

ARKO Corp. reported a net loss of $12.7 million for the first quarter of 2025, compared to a net loss of $0.6 million in the prior year. Adjusted EBITDA was $30.9 million, down from $33.2 million. Total revenues for the quarter were $1.83 billion.

• Net loss for the quarter was $12.7 million, an increase from $0.6 million in the prior year.
• Adjusted EBITDA for the quarter was $30.9 million, down from $33.2 million in the prior year.

Peakstone Realty Trust reported a net loss of $49.4 million in Q1 2025, a significant decrease from a net income of $5.0 million in the same quarter last year, primarily due to strategic office property dispositions and a real estate impairment provision. Total revenue also decreased to $57.0 million from $59.2 million. The company is advancing its strategic shift to an industrial REIT, with a focus on industrial outdoor storage, reporting a 10% increase in IOS ABR driven by leasing activity.

• Net loss attributable to common shareholders was $49.4 million, or $(1.35) per share, compared to net income of $5.0 million, or $0.14 per share, in Q1 2024.
• Total revenue was $57.0 million, down from $59.2 million in the prior year quarter, mainly due to strategic office dispositions.

Funko delivered first-quarter 2025 net sales within its guidance range, with gross margin and adjusted EBITDA exceeding expectations. However, due to increasing uncertainty and volatility surrounding global tariff policies, the company withdrew its full-year 2025 outlook.

• Net sales in Q1 2025 were $190.7 million, a decrease from $215.7 million in Q1 2024.
• Gross profit was $76.9 million, resulting in a gross margin of 40.3%, an improvement from 40.0% in the prior year period.

CVRx, Inc. announced its first quarter 2025 financial and operating results, reporting a total revenue of $12.3 million, a 15% increase year-over-year. The company significantly reduced its net loss to $13.8 million from $22.2 million in the prior year, driven by decreased operating expenses, particularly in selling, general, and administrative costs. Active implanting centers grew to 227, and real-world evidence supported Barostim's effectiveness in reducing hospital visits.

• Total revenue for Q1 2025 was $12.3 million, marking a 15% increase compared to the prior year quarter.
• Net loss significantly decreased to $13.8 million ($0.53 per share) in Q1 2025, down from $22.2 million ($1.04 per share) in Q1 2024.

ZimVie Inc. reported first quarter 2025 financial results with net sales of $112.0 million, a 5.2% decrease from the prior year. The company significantly improved its net loss, reducing it to $(2.6) million from $(11.5) million in the first quarter of 2024. Adjusted EBITDA also saw a substantial increase.

• Net Sales from Continuing Operations were $112.0 million, a decrease of 5.2% reported and 4.1% in constant currency compared to Q1 2024.
• Net Loss from Continuing Operations improved significantly to $(2.6) million from $(11.5) million in Q1 2024, with the net loss margin improving by 740 basis points.

SIGA Technologies reported total revenues of $7.0 million for the first quarter of 2025, a significant decrease from $25.4 million in the same period last year. The company experienced a net loss of $0.4 million, or $0.01 per diluted share, compared to a net income of $10.3 million, or $0.14 per diluted share, in Q1 2024. Despite the decline in sales, SIGA highlighted steady progress on key initiatives and anticipated substantial sales in the coming months from outstanding orders.

• Total revenues for Q1 2025 were $7.0 million, down from $25.4 million in Q1 2024.
• The company reported a net loss of $0.4 million in Q1 2025, compared to a net income of $10.3 million in Q1 2024.

Leslie's, Inc. reported a decrease in sales and gross profit for the second quarter of fiscal 2025 compared to the prior year, with sales reaching $177.1 million and a net loss of $51.3 million. Despite weather impacts affecting topline, the company delivered adjusted EBITDA in line with expectations and reaffirmed its full-year guidance.

• Sales decreased by 6.1% to $177.1 million in Q2 fiscal 2025 compared to $188.7 million in the prior year period.
• The company reported a net loss of $51.3 million for the quarter, compared to a loss of $34.6 million in the prior year period.

Jumia's Q1 2025 performance showed a revenue decline to $36.3 million and an operating loss of $18.7 million, impacted by lower corporate sales and currency effects. Order volume and customer base grew, and cash reserves remained strong.

• Revenue dropped to $36.3 million, primarily due to reduced corporate sales in Egypt.
• Operating loss widened to $18.7 million from $8.3 million in Q1 2024.

Delcath Systems achieved a strong start to 2025 with significant revenue growth, reaching $19.8 million, up from $3.1 million in the prior year. The company also reported its first quarter of net income of $1.1 million and positive operating cash flow, driven by the accelerating clinical adoption of HEPZATO.

• Total revenue for Q1 2025 was $19.8 million, a substantial increase from $3.1 million in Q1 2024.
• The company achieved a net income of $1.1 million in Q1 2025, a significant improvement from a net loss of $11.1 million in Q1 2024.

Gray Media, Inc. announced its financial results for the first quarter ended March 31, 2025, with total revenues exceeding guidance and operating expenses below guidance. The company reported a net loss of $22 million, a decrease from a net income of $75 million in Q1 2024, primarily due to a cyclical decrease in political advertising revenue. The company also reduced its outstanding debt by $17 million.

• Total revenue for Q1 2025 was $782 million, a 5% decrease from Q1 2024 but 1% above the high end of guidance.
• Net loss attributable to common stockholders was $22 million in Q1 2025, compared to net income of $75 million in Q1 2024.

Eventbrite reported a solid start to 2025 with Q1 results at the high end of guidance, driven by improvements in paid tickets, creators, and events. Despite a year-over-year revenue decrease due to the elimination of organizer fees, the company saw rapid growth in Eventbrite Ads and maintained financial discipline, positioning for a return to profitable growth.

• First quarter revenue of $73.8 million met the upper end of the company's outlook.
• Paid ticket volume showed sequential improvement for the third consecutive quarter.

Acacia Research Corporation announced a strong start to 2025, with total revenue reaching $124.4 million and Total Company Adjusted EBITDA of $50.7 million. These results were primarily fueled by $69.9 million in revenue from Intellectual Property operations, strong performance from Deflecto, and continued execution at Benchmark and Printronix.

• Total revenue for Q1 2025 was $124.4 million, a 412% increase compared to the prior-year quarter.
• GAAP Net Income for the quarter was $24.3 million, resulting in $0.25 GAAP Diluted EPS.

Nu Skin Enterprises reported first quarter 2025 revenue of $364.5 million, which was at the high end of their guidance. The company's EPS was $2.14, or $0.23 excluding Mavely gain and other charges. They saw year-over-year growth in Latin America and their Rhyz manufacturing segment, but experienced consumer caution in premium beauty due to inflation and tariffs.

• Revenue reached $364.5 million, aligning with the upper end of the guidance.
• Diluted EPS was $2.14, significantly higher than the previous year's $(0.01).

BRT Apartments delivered stronger operational results in Q1 2025 with notable increases in Funds From Operations and Adjusted Funds From Operations. Although the company posted a net loss, stabilized occupancy and moderate rent growth helped maintain income stability across its portfolio.

• Net loss of $2.35 million or $(0.12) per share, improved from $(0.17) in Q1 2024.
• Funds From Operations (FFO) grew to $5.72 million, or $0.30 per diluted share.

Kaltura, Inc. announced strong financial results for the first quarter ended March 31, 2025, exceeding guidance with record total and subscription revenue. The company achieved significant improvements in GAAP and non-GAAP net loss, reaching a record positive Adjusted net income and earnings profitability per share. Annualized Recurring Revenue (ARR) and net dollar retention rate also saw record highs.

• Revenue for Q1 2025 increased by 5% to $47.0 million compared to Q1 2024.
• Subscription Revenue grew by 9% to $44.9 million in Q1 2025.

Amprius demonstrated strong performance in Q1 2025, shipping batteries to over 100 customers and introducing new cell chemistries. The company reported significant revenue growth, driven by increased SiCore shipments and new customer acquisitions, while maintaining a strong financial position with adequate cash reserves and no debt.

• Amprius shipped batteries to over 100 customers in Q1 2025, including 46 new customers.
• Revenue for Q1 2025 was $11.3 million, a 6% increase sequentially and a 383% increase year-over-year.

Amylyx Pharmaceuticals reported a net loss of $35.9 million for the first quarter of 2025, a significant improvement compared to the $118.8 million net loss in the same period last year. The company's cash position strengthened to $204.1 million, extending its expected cash runway through the end of 2026. The quarter saw continued progress in clinical trials, particularly the pivotal Phase 3 LUCIDITY trial for avexitide in PBH and the initiation of the Phase 1 LUMINA trial for AMX0114 in ALS.

• Net loss improved significantly to $35.9 million in Q1 2025 from $118.8 million in Q1 2024, primarily due to the discontinuation of RELYVRIO/ALBRIOZA sales and associated costs.
• Cash, cash equivalents, and marketable securities increased to $204.1 million as of March 31, 2025, supported by a public offering, extending the cash runway through the end of 2026.

Expensify delivered a strong Q1 2025, exceeding expectations with an 8% increase in revenue, a 43% increase in interchange, and a 75% increase in free cash flow compared to the prior year. The company also saw a 166% quarter-over-quarter increase in travel bookings and raised its full-year 2025 free cash flow guidance.

• Revenue increased by 8% to $36.1 million compared to the same period last year.
• Total interchange derived from the Expensify Card grew by 43% to $5.1 million.

Montauk Renewables reported total revenues of $42.6 million for the first quarter of 2025, a 9.8% increase from the same period in 2024. However, the company experienced a net loss of $0.5 million, a significant decrease from the net income of $1.9 million in the first quarter of 2024. Adjusted EBITDA also saw a decline of 7.2% year-over-year.

• Revenues increased by 9.8% to $42.6 million in Q1 2025 compared to Q1 2024, primarily driven by the monetization of RINs from 2024 RNG production.
• The company reported a net loss of $0.5 million in Q1 2025, a decrease from a net income of $1.9 million in Q1 2024.

BlackSky Technology Inc. announced strong first-quarter results for 2025, with total revenue increasing by 22% year-over-year to $29.5 million. The company secured over $130 million in new contract bookings, boosting its backlog to $366 million. The first Gen-3 satellite is fully commissioned and exceeding performance expectations, with the second Gen-3 satellite on track for launch in Q2.

• Total revenue increased by 22% over the prior year period to $29.5 million.
• New contract bookings exceeded $130 million in Q1, leading to a 40% growth in backlog to $366 million.

OmniAb reported a robust first quarter in 2025 with increased revenue driven by milestone payments and higher license fees, alongside a reduced net loss due to lower operating expenses. The company also announced strategic initiatives like the xPloration® Partner Access Program and affirmed its 2025 financial guidance.

• Revenue for Q1 2025 increased to $4.2 million from $3.8 million in Q1 2024, primarily due to a $1.0 million Phase 1 milestone payment and higher license fees.
• Net loss for Q1 2025 decreased to $18.2 million, or $0.17 per share, compared to $19.0 million, or $0.19 per share, in Q1 2024.

Berry Corporation reported a net loss of $97 million in Q1 2025, impacted by a non-cash impairment. Despite this, the company generated positive operating cash flow, Adjusted EBITDA, and Free Cash Flow. Production was in line with plans, and the company maintained a strong hedge position and increased liquidity while reducing debt.

• Reported a net loss of $97 million, including a non-cash impairment of $113 million.
• Generated Adjusted Net Income of $9 million, or $0.12 per diluted share.

Terns Pharmaceuticals reported a net loss of $23.9 million for the first quarter of 2025, compared to a net loss of $22.4 million for the same period in the prior year. The company ended the quarter with $334.3 million in cash, cash equivalents, and marketable securities, which is expected to fund operations into 2028. The company highlighted progress in its clinical programs, with dose expansion initiated for TERN-701 in CML and good enrollment in the FALCON trial for TERN-601 in obesity, with key data readouts expected in Q4 2025.

• Net loss for Q1 2025 was $23.9 million, an increase from $22.4 million in Q1 2024.
• Cash, cash equivalents, and marketable securities totaled $334.3 million as of March 31, 2025, providing runway into 2028.

COMPASS Pathways plc, a biotechnology company focused on mental health innovation, reported a net loss of $17.864 million for the three months ended March 31, 2025, a significant improvement compared to a net loss of $35.187 million for the same period in 2024. This improvement was largely due to a $19.460 million fair value change of warrant liabilities and an increased R&D tax credit of $8.448 million. The company continues to incur operating losses as it advances its Phase 3 program for COMP360 psilocybin treatment in TRD, with total operating expenses increasing to $49.616 million from $38.573 million in the prior year.

• Net loss significantly improved to $17.864 million in Q1 2025 from $35.187 million in Q1 2024.
• Total operating expenses increased to $49.616 million in Q1 2025, up from $38.573 million in Q1 2024, driven by higher research and development costs.

Xponential Fitness, Inc. reported a total revenue of $76.9 million for Q1 2025, a 4% decrease from the prior year. The company posted a net loss of $2.7 million, or $0.10 per basic share. Despite the revenue decline, North America system-wide sales increased by 18% to $466.8 million, and quarterly average unit volume grew by 8% to $659,000.

• Total revenue for Q1 2025 decreased by 4% to $76.9 million compared to the prior year period.
• The company reported a net loss of $2.7 million, or $0.10 per basic share, an improvement from a net loss of $3.8 million in the prior year.

Corvus Pharmaceuticals reported a net income of $15.2 million for the first quarter of 2025, a significant improvement compared to a net loss in the prior year, primarily driven by a substantial gain from the change in the fair value of the warrant liability. The company also provided positive updates on its clinical pipeline, particularly for soquelitinib in atopic dermatitis and peripheral T cell lymphoma, and reported additional cash from warrant exercises.

• Interim results from the Phase 1 soquelitinib trial in atopic dermatitis showed favorable safety and efficacy, with earlier and deeper responses in the higher dose cohort.
• Enrollment is ongoing in the Phase 3 registrational clinical trial of soquelitinib in peripheral T cell lymphoma at multiple sites.

The E.W. Scripps Company reported first-quarter 2025 revenue of $524 million, a decrease of 6.6% from the prior year, and a net loss attributable to shareholders of $18.8 million, or 22 cents per share. Despite the revenue decline, the company successfully refinanced its debt, improved Scripps Networks margins to 32%, and generated $63 million from real estate sales.

• First-quarter 2025 revenue was $524 million, a decrease of 6.6% from the prior-year quarter.
• Net loss attributable to shareholders was $18.8 million, or 22 cents per share, compared to a loss of $12.8 million, or 15 cents per share, in the prior-year quarter.

Nerdy's Q1 2025 performance showed a revenue of $47.6 million, an 11% decrease year-over-year, and a net loss of $16.2 million. Despite the revenue decline, the company saw a 14% improvement in Average Revenue per Member per Month (ARPM) to $335 and positive inflection in monthly recurring Learning Membership revenue, indicating the effectiveness of its quality-of-revenue strategy. Gross margins were impacted by increased tutor incentives, but the company anticipates sequential improvements throughout the year.

• Revenue for Q1 2025 was $47.6 million, an 11% decrease year-over-year, but at the top end of guidance.
• Average Revenue per Member per Month (ARPM) increased by 14% year-over-year to $335, driven by pricing increases and a mix shift to higher frequency Learning Memberships.

TTEC exceeded its internal plan in the first quarter of 2025 with both the TTEC Digital and TTEC Engage segments delivering strong results. Despite a cautious economic environment and uncertainty in trade policy, the company signed new enterprise clients, grew existing client relationships, and improved operational performance. The company is reiterating its full-year 2025 outlook.

• First quarter 2025 GAAP revenue was $534.2 million, a 7.4 percent decrease compared to $576.6 million in the prior year.
• GAAP income from operations was $24.2 million, or 4.5 percent of revenue, compared to $22.7 million, or 3.9 percent of revenue in the prior year.

Inseego Corp. reported Q1 2025 revenue of $31.7 million and positive Adjusted EBITDA of $3.7 million, marking the ninth consecutive quarter of positive Adjusted EBITDA. The company delivered results within expectations, maintained strong adjusted EBITDA profitability, and made progress on strategic initiatives including repaying convertible debt.

• Q1 2025 revenue was $31.7 million.
• Q1 2025 Adjusted EBITDA was $3.7 million, an increase of $2.2 million year-over-year.

Silvercrest Asset Management Group Inc. reported a revenue of $31.4 million for Q1 2025, an increase from the previous year. The company experienced strong new client organic flows of $0.4 billion, contributing to growth initiatives. However, total AUM declined to $35.3 billion due to market volatility.

• Revenue increased by 3.7% to $31.4 million for Q1 2025 compared to Q1 2024.
• Strong new client organic flows of $0.4 billion were reported in Q1 2025.

Nektar Therapeutics reported a net loss of $50.9 million for the first quarter of 2025, or $0.24 per share, compared to a net loss of $36.8 million, or $0.19 per share, in the same period last year. Total revenue decreased to $10.5 million from $21.6 million in Q1 2024, primarily due to the sale of the Huntsville manufacturing facility. Operating costs and expenses decreased slightly to $55.0 million.

• Revenue for Q1 2025 was $10.5 million, a decrease from $21.6 million in Q1 2024, primarily due to the sale of the Huntsville manufacturing facility.
• Net loss for Q1 2025 was $50.9 million, or $0.24 per share, compared to a net loss of $36.8 million, or $0.19 per share, in Q1 2024.

BeautyHealth reported first quarter 2025 results with net sales of $69.6 million, a decrease of 14.5% year-over-year, primarily due to lower delivery system sales. Despite the revenue decline, the company improved its gross margin and adjusted EBITDA, driven by cost efficiencies and a favorable shift towards consumables revenue.

• Net sales for Q1 2025 were $69.6 million, a decrease of 14.5% compared to Q1 2024.
• Gross margin improved to 69.8% in Q1 2025, up from 59.4% in Q1 2024.

The Joint Corp. reported a 7% increase in revenue from continuing operations to $13.1 million in Q1 2025, alongside a 5% rise in system-wide sales to $132.6 million, demonstrating economic resilience despite a net loss from continuing operations of $506,000.

• Revenue from continuing operations grew 7% to $13.1 million compared to Q1 2024.
• System-wide sales increased 5% to $132.6 million, indicating economic resilience.